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Abstract 
The objective of this thesis was to investigate the use of mid-infrared spectroscopy 
(MIR) as a PAT tool in bioprocessing.  This was achieved through the development of 
chemometric models from MIR spectroscopic data.  Models were applied to both 
upstream and downstream bioprocess steps to evaluate the potential of MIR as a PAT 
tool in each scenario.   
 
The first study included a preliminary examination of 8 typical components found in a 
mammalian cell culture medium.  A multivariate limit of detection (LOD) analysis was 
performed to establish the monitoring potential of the instrument for the given 
application.  This initial work identified the components which were unlikely to be 
accurately detected, such as glutamine, but also highlighted the components that 
showed promise, such as glucose.  A 7-level experimental design was used to develop 
partial least squares regression (PLS) models for each of the 8 components, with 
optimal model errors ranging from 6.03% for glucose to 63.06% for glutamine.  An 
external influence investigation into the factors likely to impact model prediction 
ability was also performed.  A statistical analysis on these influences enabled the 
significance of the effect to be determined.  Finally, all investigative work performed 
in this study was completed using 2 MIR immersion probes; the first, a fixed conduit 
immersion probe and the second, a flexible fibre-optic immersion probe.  This allowed 
for a comparative analysis of probes and identified the fixed conduit probe as the most 
suitable for the given application. 
 
The second study applied models developed for glucose and lactate, in the first study, 
to a series of CHO DP12 cell cultures.  The objective of this work was to investigate 
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how effective the previously developed models were at predicting glucose and lactate 
concentrations when applied in-situ, in a bioreactor.  This study explored the at-line 
application of MIR and showed an improvement of 60.27% for glucose and 13.22% 
for lactate predictions, when applied at-line rather than in-situ.  Central to this study 
was the optimisation of the models used, in an effort to improve their accuracy and 
robustness.  The impact of the size and nature of the calibration set was investigated to 
identify the optimum calibration set for in-situ and at-line model development.  When 
offline data was used as part of the optimised calibration training set, models 
consistently performed better than the original partial least squares regression (PLS) 
models, created solely from synthetic samples.  Optimised glucose model results 
showed an improvement in RMSEP of 37.93% while optimised lactate model results 
had an improved RMSEP of 61.98%.  
 
The third and final study presented here investigated the use of MIR as a qualitative 
and quantitative tool for total and recombinant protein detection.  Exploratory work to 
establish the instruments capability in distinguishing between differing proteins was 
initially performed via principal component analysis (PCA).  This showed that the 
instrument used could identify the recombinant protein of interest among a group of 5 
other standard proteins.  In-process samples, provided by an industrial collaborator, 
were used to develop PLS models for total and recombinant protein prediction.  
Results indicated that models performed better for total protein quantification, with the 
minimum percentage error of prediction, (PEP) 2.39%.  The smallest PEP for the 
recombinant protein was found to be 6.66%.  This study was completed with an 
investigation into the likely impact of 2 detergents on model performance.  Due to the 
common usage of detergents in protein production, for e.g. protein solubilisation or 
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virus inactivation, the effect of these on MIR spectra and consequently models 
predictions was investigated.  This analysis indicated that detergents were likely to 
impact results, particularly at concentrations at the higher end of the typically used 
range.   
 
This thesis establishes and evaluates the potential of MIR spectroscopy as a PAT tool.  
It presents 3 studies which highlight development methodologies and outline possible 
applications, all the while seeking to optimise results obtained.  Through systematic, 
novel investigations this thesis shows that MIR can be used as a PAT tool, but equally, 
it raises warnings of when the technique or analysis methods may fall short of the 
desired result.      
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Chapter 1:  Introduction 
The field of biotechnology has undergone exceptional growth in the last decade.  There 
is an ever increasing global demand for high quality biopharmaceuticals at lower costs.  
The pharmaceutical industry has previously experienced such mounting pressure; but 
with market focus shifting to biopharmaceuticals, it is now the turn of the 
biotechnology sector to accept the torch and take a leading role in embracing dynamic 
initiatives such as “Process Analytical Technology (PAT) and Quality by Design 
(QbD)”.  Although these initiatives are almost a decade old, their introduction to the 
biopharmaceutical industry is still in its infancy.  However the search has begun to find 
robust and reliable techniques to enable the concept of Process Analytical Technology 
(PAT) to take root within the industry. 
 
The production of recombinant proteins for therapeutic and diagnostic applications is 
developing at an extremely high rate, principally based on microbial and animal cell 
production systems.  The efficient control of cell culture conditions such that very high 
cell densities may be attained, is hugely desirable.  However, reaching high cell 
densities is not the only challenge.  Maintaining and controlling this high cell 
concentration over the course of the cell culture is even more critical. Uncontrolled 
systems may lead to extreme loss in viability, high release of proteolytic enzymes and, 
hence lower protein productivity and increase protein degradation in the bioreactor.1  
Therefore systems capable of tight control to ensure high product yield and quality are 
imperative.  This is generally achieved by careful formulation of the culture medium, 
coupled with controlled feeding of the medium through fed-batch or perfusion 
systems, to simultaneously maintain high cell viability and high production rates, 
while maintaining the required product quality.   
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The increasing demand for improved process efficiency and consistent product quality 
in bioprocessing has fuelled extensive research efforts in the area of on-line bioprocess 
monitoring and control.  An important driving force for this growth was set in place by 
the Process Analytical Technology (PAT) initiative, proposed in 2002 by the Food and 
Drug Administration (FDA).2  PAT endeavours to establish in the pharmaceutical 
industry, the ideology of Quality by Design, QbD, where continuous on-line process 
monitoring and supervision ensure optimum manufacturing conditions, allow complete 
product traceability and quality control, as well as improve early fault detection.  In 
addition, the implementation of PAT to a process ultimately results in greater process 
understanding as it effectively monitors, and controls if necessary, all the Critical 
Process Parameters (CPP’s) hence providing considerable insight into the Critical 
Quality Attributes (CQA’s) of the process.3  The availability of real-time analytical 
results has been shown to reduce production costs by reducing losses caused by 
unnecessary waiting periods between process steps, for example, results from in-
process testing.  Also, costs incurred due to batch failures and reworks are significantly 
reduced.4 
 
Several ‘conventional’ bioprocess monitoring techniques are widely used; temperature, 
pH, dissolved oxygen, carbon dioxide etc.  These analysers, most often in the form of 
in-situ probes, are used mainly for controlling the corresponding process parameters, 
although they do not provide much insight into the reaction itself.  Analysers capable 
of providing information on the contents of a bioreactor at any point in time perhaps 
provide the greatest insight into the bioprocess.  A major challenge currently in the 
area of bioprocess monitoring lies in ensuring the reliability of monitoring tools and 
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the accuracy of the measurements they provide in on-line conditions.  As the 
concentrations of the major analytes and metabolites in biotechnological applications 
are typically very low, achieving the required reliability and precision of on-line 
measurements often proves a difficult task.  On-line monitoring tools provide reliable, 
instantaneous analytical information about the bioprocess, which in turn can be used 
for advanced control schemes aimed at optimising the process in real-time.  PAT 
instruments in a bioprocess application should meet certain criteria.  They should be 
capable of rapid and accurate on-line monitoring with the ability to be integrated into 
reliable and robust calibration systems as well as being non-invasive and non-
destructive.  These applications should also provide dependable analytical feedback to 
continually maintain the desired operational parameters and allow for implementation 
of stringent process control mechanisms.  
 
Vibrational spectroscopy has huge potential as a PAT tool in bioprocess monitoring.  
In-situ probes meet much, if not all of the criteria listed above.  These probes can be 
sterilised in place, do not require any sample preparation and can produce 
spectroscopic data in seconds.5  Infrared spectroscopy; near-infrared (NIR) and mid 
infra-red (MIR), work on the basis of detecting the vibration characteristics (stretching, 
contracting, bending, etc.) of various chemical functional groups over the specific 
infrared frequency range of light.  Another vibrational spectroscopic technique, Raman 
spectroscopy, is complementary to infrared spectroscopy and is based on light 
scattering.  Previous studies have demonstrated the application of NIR, MIR and 
Raman spectroscopy to cell cultures for the simultaneous on-line monitoring of media 
analytes and metabolites.6-12  Other studies have highlighted the use of infra-red 
spectroscopy as a rapid technique for recombinant protein detection, outlining its 
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capabilities in protein characterisation and quantification.13-16  However these uses 
have yet to be significantly demonstrated in an on-line capacity.   
 
The useful information embedded within spectral data sets needs to be extracted if it is 
to be of use as part of a monitoring and/or control strategy.  It is the development of 
multivariate calibration models which is the key to unlocking this information.  In the 
case of spectroscopic data, a large number of independent variables are generated 
which relate to one predicted dependent variable e.g. absorbance values (independent 
variables) over a range of wavenumbers in the mid-infrared region can be used to 
predict the concentration (dependent variable) of a particular component.  These 
variables are related to each other by a calibration model.   
 
Chemometrics (multivariate analysis techniques) are used to establish correlations 
between a dependent variable, such as concentration, and absorbance.  They are often 
used as data reduction techniques since chemometric analysis allows multivariate data 
to be transformed into a much smaller number of variables.  The important information 
is maximised and system noise is minimised.  A number of chemometric techniques 
can be employed, depending on the required information.  In the studies presented in 
this thesis, the chemometric techniques used were principle component analysis (PCA) 
and partial least squares regression (PLS).  PCA is often used for exploratory analysis 
and pattern recognition.  In bioprocessing, PCA can be used as a qualification 
technique for raw materials or products where differences between samples may be 
highlighted.  PLS is a supervised method which requires the use of a training or 
calibration set to develop a predictive model.  It is frequently used in the generation of 
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calibration models capable of predicting the concentrations of various components 
present in a system.   
 
The overall aim of this thesis was to establish the potential of MIR as a PAT tool in 
bioprocessing.  This was achieved by employing chemometric techniques to develop 
calibration models capable of predicting the concentrations of analytes and metabolites 
present in a mammalian cell culture medium.  These models were applied in real-time 
to a series of cultures and the efficacy of the technique for analyte and metabolite 
measurement was evaluated.  The applicability of this technique in the monitoring of 
product, in the form of recombinant protein, was investigated by development of PLS 
models from spectral data obtained from in-process culture samples.  Three separate 
studies were completed in order to carry out all aspects of the research outlined above. 
 
Study 1 proposed a methodology on how to develop and evaluate MIR spectroscopy as 
a PAT tool in the quantification of media components.  This work identified 8 
components typically present in a mammalian cell culture medium and systematically 
examined each one in terms of the ability of MIR to detect and accurately predict its 
concentration.   
 
Study 2 applied the PLS models developed for glucose and lactate in study 1, to 
mammalian cell cultures in real time to determine the accuracy of these models.  This 
study also highlighted the differences when the technique was applied on-line and at-
line. 
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Finally, study 3 focused on the ability of MIR to detect total and recombinant protein 
in samples taken directly from the primary recovery stage of an industrial process.  
This exploratory work investigated the potential of in-situ MIR as a PAT tool for 
qualitative and quantitative protein analysis. 
 
All 3 studies presented in this thesis provide a cohesive approach to determining the 
ability of MIR to perform effectively as a PAT tool in bioprocessing.  Both upstream 
(in the form of mammalian cell culture cultivation) and downstream (in the form of 
primary recovery) processing is considered.  In addition to evaluating the potential of 
MIR as a PAT tool, each of the individual studies raises questions as to optimum 
methodologies, with limit of detection, calibration set type and means of evaluation, all 
scrutinised.     
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Chapter 2:  Literature Review 
The choice of suitable on-line analytical techniques and data processing for 
monitoring of bioprocesses 
 
Adapted from the Springer Berlin Heidelberg publication:  Advances in Biochemical 
Engineering Biotechnology, Volume “Stage of the Art of M3C”, 2012.  Series ISSN 
0724-6145 
 
Abstract 
With increasing pressure from regulatory authorities on industry to develop processes 
embracing ‘Process Analytical Technology’ (PAT) initiatives, there is a growing 
demand to establish reliable tools and systems capable of meeting this need.  With 
regard to monitoring and control of bioprocesses, this need translates to a search for 
robust instrumentation capable of monitoring the critical process parameters in real 
time.  The application of such technologies at all stages of the process, from the initial 
R&D phase, to process optimisation and production enhances process understanding 
and paves the way for the development of control platforms.  
 
An examination of the PAT concept and selected tools are presented here.  A 
description of each tool is given, with particular emphasis on the nature of the signal 
produced and how these relate to measurements of biomass, metabolites and product.  
A description of the signal processing that is necessary to gain meaningful results from 
the different tools is also given.  Many techniques such as those based on vibrational 
spectroscopy are of particular interest, since they are capable of monitoring several 
critical process parameters which are typically controlled in a bioprocess.   A window 
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of application for each of the techniques, when used in the area of bioprocessing, is 
suggested based on their uses and inherent limitations.            
 
Keywords PAT, Critical Process Parameters, Bioprocess Monitoring, Spectroscopy, 
Calorimetry, Data Reconciliation, Bioprocess Control 
 
2.1  Introduction 
The last decade has introduced a significant number of changes to the pharmaceutical 
and biopharmaceutical industries, not least in the area of quality assurance and 
regulatory compliance.  This new focus has largely been driven by the Food and Drug 
Administration (FDA).  In 2002 the FDA announced a new initiative, “Pharmaceutical 
cGMPs for the 21st Century”, the purpose of which was to modernise the regulation of 
pharmaceutical quality.  The initiative supports and promotes the use of risk-based and 
science-based approaches for regulatory decision making, throughout the entire life-
cycle of a product.1  After 2 years in development, the final report outlines the 
envisioned direction in which the pharmaceutical and biopharmaceutical industries 
should be moving, but also provides guidance on how to make the proposed changes 
and embrace the new concepts put forward.   
 
Central to the implementation of this new system is the use of science and engineering 
knowledge to establish boundaries and evaluate processes.  Previously, a 
manufacturing process was developed and quality control and quality assurance tests 
were then applied to ensure compliance.  This new initiative aims to use science and 
engineering knowledge to mitigate risk, by reducing process and product variability 
and applying continuous process improvement.  Industry guidelines published by the 
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FDA in May 2006, “Q8 Pharmaceutical Development”, state, “quality cannot be tested 
into the products, it should be built in by design”.2  Essentially this means that the 
rigorous testing of the past cannot improve product quality or enhance the process but 
rather quality should be pivotal throughout the lifecycle of a process and a key factor 
from the initial stages of development and process design.  This introduces the concept 
of “Quality by Design” (QbD), whereby a “design space” is established, within which, 
the product quality profile is defined, the critical quality attributes (CQAs) and critical 
process parameters (CPPs) are identified and the manufacturing process is controlled.  
Process changes that occur within the design space are acceptable as the design space 
would have been subject to regulatory assessment and approval at the time the 
manufacturing process was filed.  However movement outside the design boundary is 
considered a change and as such would most likely require regulatory post approval. 
 
In order to establish a design space that will allow for maximum process flexibility 
while ensuring all CPPs and CQAs are identified and maintained, a large degree of 
process understanding is essential.  Process analytical technology (PAT) is a 
“pillar/guiding principle” of the cGMP initiative.1  The PAT framework published in 
September 2004 defines process understanding and highlights the tools required to 
achieve this standard of process knowledge: 
“A process is generally considered well understood when (1) all critical sources of 
variability are identified and explained; (2) variability is managed by the process; 
and, (3) product quality attributes can be accurately and reliably predicted over the 
design space established”3  
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PAT provides in depth process understanding, but to implement PAT and operate 
under the principle of Quality by Design the process must be well understood.  At the 
point of writing this chapter, the initiative is still in its infancy with regard to industrial 
implementation, and so a large degree of progress has been in the area of PAT tool 
development.  With research and development focused on process analysers and data 
acquisition tools, many in the industry have applied these to processes to glean greater 
process knowledge.  However, although PAT is a relatively new concept it has evolved 
over the last decade.  It has transitioned from being an analysis in the process, to 
supplement quality control, to being an analysis of the process.4  
 
As already mentioned the main driver of this initiative is the FDA, however the 
pharmaceutical and biopharmaceutical industries are a close second.  They strive to 
ensure that products released to market are of the highest quality and compliant with 
regulations.  This reason alone merits acceptance of these new guidelines, however 
there are other benefits.  Live feedback and process control, reduced cycle times, 
laboratory test replacement and improved safety result in increased product yield and 
quality, reduction in batch failures and rework costs and increased throughput.  Such 
changes result in continuous improvement and operational excellence, which in turn 
increases business value.   As a result of PAT being embraced by industry, tools must 
be developed that are capable of real-time monitoring and control.  Currently very few 
developed tools exist and even fewer have actually been implemented in a 
manufacturing environment.  
 
This chapter explores the use of selected PAT tools which can be used in the context of 
M3C in bioprocess applications and looks at the advantages and limitations of each.  
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Vibrational spectroscopic instruments as PAT analysers are examined.  The theory 
behind the use of MIR, NIR and Raman spectroscopy for bioprocessing applications is 
stated and necessity of using multivariate data processing is explained.  Reported uses 
of these techniques for bioprocess monitoring and control applications are summarised 
and the current state of the different technologies are compared. 
 
2.2  Vibrational Spectroscopy 
The energy of a molecule is quantised and can only exist in certain discrete energy 
levels, E0, E1, E2 etc.  When a photon (energy in the form of light) is emitted from a 
light source, a molecule will only absorb this energy if it equates to the difference in 
energy between these discrete energy levels.  The energy emitted by the light or 
absorbed by the molecule is related to the frequency by the following equation: 
E = hυ                                                            (2.1) 
where; E is the energy emitted or absorbed, h is Plank’s constant and υ is the 
frequency.  As the energy is directly proportional to the frequency, it therefore follows 
that a photon with higher frequency has a higher energy.  The energy absorbed by the 
molecule results in molecular vibrations.  These vibrations can take any of the 
following forms: stretching, bending, rocking, wagging and twisting.  In order for a 
molecule to absorb infrared radiation the frequency of the radiation must equal the 
frequency of the molecular vibration and this vibration must cause a change in the 
dipole moment of the molecule.  
 
Infrared spectroscopy is concerned with the region of the electromagnetic spectrum 
between the visible and microwave regions.  This region, the infrared region, is further 
broken down into the near-infrared region (12,500-4000cm-1/800-2500nm), mid-
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infrared region (4000-400cm-1/2500-25000nm), and far-infrared region (<400cm-
1/>25000nm).   
 
 
 
 
Fig. 2.1  Electromagnetic Spectrum 
 
Energy in the mid-infrared region has lower frequency and so lower energy than that 
of the near-infrared region.  Mid-infrared spectroscopy looks at the change in energy 
when the molecule is radiated and moves from the ground state to the next excited 
energy level.  This is the fundamental energy change.  As a result absorption bands 
within the mid-infrared region can be attributed to specific molecules or functional 
groups within the molecule; hence MIR spectroscopy is sometimes referred to as a 
“fingerprinting” technique.  The higher energy of the near-infrared region results in the 
radiated molecule moving from the ground state to excited energy levels above the 
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fundamental absorption state, therefore NIR is focused on the combination bands and 
overtones.   
 
 
Fig. 2.2  MIR energy level diagram 
 
 
 
 
 
 
 
 
Fig. 2.3  NIR energy level diagram 
 
Spectra are most commonly presented in terms of “intensity ‘v’ wavenumber” or 
“absorbance ‘v’ wavenumber”.  The absorbance and concentration can be calculated 
using the Beer-Lambert Law as follows: 
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where : 
Av = absorbance at wavenumber v 
Iv = intensity of the light emitted from the sample at wavenumber v  
Iv,0 = intensity of the light emitted from the background (usually water or air) at 
wavenumber v 
ε = Molar absorption coefficient  
b = pathlength 
c  =  concentration 
 
Put more simply, the absorbance of a component at a particular 
wavenumber/wavelength is directly proportional to the concentration of that 
component.  In order to transform spectral data into meaningful results it is necessary 
to develop a calibration model which relates the absorbance to concentration values, 
much the same as a mercury thermometer relates increase in height to temperature.  In 
the case of the thermometer there is only one independent (measured) variable; the 
height of the mercury in the tube. This is referred to as a univariate model.  Where 
spectral data are concerned, there are several independent variables; the multiple 
absorbance values over the range of the MIR or NIR spectrum.  This is referred to as a 
multivariate model.  Chemometric techniques are exploited to extract the relevant data, 
and in this way act as a key to unlocking the information buried within the spectral 
data. 
 
Raman spectroscopy is a technique which is complementary to infrared spectroscopy 
and is based on the scattering of light. When a monochromatic light of given frequency 
  Chapter 2
   
 18 
 
is directed at a molecule, most photons of energy will be elastically scattered and this 
is known as Rayleigh scattering.  A small fraction (1 in 108 photons) of the light will 
exchange energy with the molecule.  This is inelastic or Raman scattering. 5, 6  Figure 
2.4 is an energy level diagram showing the different scattering phenomena.  Scattering 
is a two photon process with one photon being absorbed and a second photon being 
emitted.  With elastic Rayleigh scattering, the energy of the photon absorbed and the 
molecule is excited to a virtual state.  The energy of the photon emitted is equal to the 
energy of the photon absorbed but with Raman scattering there is a difference between 
the energy of the absorbed and emitted photon 7  Energy can be transferred to a 
molecule excited to a virtual state and when the emitted light is scattered, the 
frequency of the photon is higher than the frequency of the original photon of light.  
This phenomenon is known as Stokes Raman scattering.  An already excited molecule 
that interacts with another photon will have excessive energy so, when scattering 
occurs, the frequency of the emitted photon is lower than that of the original photon 
and this is known as anti-Stokes Raman scattering.  In order for Raman scattering to 
occur, a change in polarizability of the molecule is necessary.  Polarizability is the 
relative ease with which a dipole moment is induced when the oscillating electric field 
of a light source interacts with a molecule. 8 
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Fig. 2.4  Energy level diagram of scattering phenomena; Rayleigh scattering (R), 
Stokes Raman scattering (S) and anti-Stokes Raman scatting (AS) 
 
In order to transform spectral data into meaningful results it is necessary to develop a 
calibration model which relates the spectra to a process parameter e.g. concentration 
values of a substrate.  Chemometric techniques are exploited to extract the relevant 
data; this will be discussed further in following sections. 
 
2.3  Development of MIR spectroscopy 
Infrared radiation was discovered in 1800 by Sir William Herschel and following this, 
the first mid-infrared spectrometer was constructed by Melloni in 1833.  In 1891 
Albert Michelson invented the interferometer which produced an interference pattern 
by splitting a beam of light into two paths, bouncing the beams back and recombining 
them.  A year later Lord Rayleigh proposed that this interference pattern could be 
converted into a spectrum using the Fourier Transformation mathematical technique.  
The first half of the 20th century saw little development in FT-IR spectroscopy and its 
potential as an analytical tool remained largely untapped until the late 1950’s and early 
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1960’s.  With huge technological advances and the advent of the computer age fast 
approaching a need for highly sensitive, rapid detection devices over a broad range of 
applications arose.  Early systems did not meet their goals, as they were hindered by 
memory size, poor stability and low resolution, so it was not until the late 1960’s and 
early 1970’s, when major technological improvements we made, that FT-IR 
instruments became commercially available.  These systems were a welcome addition 
to their dispersive counterparts as they were more sensitive, had greater wavelength 
accuracy, and allowed for rapid spectral acquisition and manipulation in the form of 
spectral subtraction.  Spectral subtraction allows the user to study mixtures of 
components without having to complete sample processing and separation prior to 
testing, thus expanding the boundaries of FT-IR spectroscopy and increasing it’s 
applicability in a number of areas e.g. bioprocess applications.   
 
Since the commercial debut of the FT-IR system in the 1970’s the technology has been 
embraced by manufacturing industries and research communities alike.  Instruments 
have been adapted and improved to meet the specific needs of the end user.  Spectral 
measurements can be in several forms; transmission of radiation, internal reflectance 
(attenuated total reflectance), external reflectance, bulk diffuse reflectance and 
photoacoustic determinations.9  In addition, the sampling configuration must be 
suitable for the instruments use.  Given the variety of sampling techniques and sample 
interfacing available; from off–line transmission cells to in-situ fibre-optic reflectance 
probes, mid-infrared spectroscopy is adaptable to almost any area.  The focus here is 
on its applicability as an on-line monitor in bioprocess applications. 
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MIR immersion probes have been available since the late 1980’s.  Improvements in the 
design and material of construction are on-going.  At the early stages of development 
MIR fibres suffered from high material absorption and scattering and poor mechanical 
and chemical stability therefore “fixed” arm probes with parallel light pipes using 
internal reflection spectroscopy were found to be more suitable.  However when 
placed in a process environment this design is far from ideal.  These probes need to be 
precisely aligned and are highly sensitive to vibrations in the surrounding area, which 
can result in alignment changes and hence spectral differences.10-12  There have been 
major advances in the development of fibre-optic materials over the last 10 years and 
these improvements have had far reaching consequences.  In the case of MIR 
instrumentation it has resulted in flexible, more robust immersion probes which 
address many of the problems encountered with the rigid conduit probes.  However 
regardless of probe type, process disturbances will regularly impact the spectra 
collected and these disturbances need to be accounted for when developing 
multivariate calibration models.  The short pathlength of MIR, when compared to that 
of NIR means that from a sampling perspective the MIR does not penetrate as far into 
the material and may not be as representative of the sample as NIR would be, however, 
in the presence of particulate matter the shorter pathlength of MIR reduces light 
scattering, which is commonly experienced when NIR is used in a similar situation.9 
 
2.4  Development of NIR spectroscopy 
In 1800, Sir William Herschel separated the electromagnetic spectrum by passing light 
through a prism.  He noted that the temperature increased significantly towards and 
beyond the red region, now referred to as the near-infrared region.  This experiment 
marked the discovery of near-infrared radiation.  However, as with mid-infrared 
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spectroscopy, near-infrared spectroscopy was not widely used in any applications until 
the second half of the 20th century when optical techniques and computers capable of 
complex analysis were rapidly developing. 
 
In the 1950’s NIR showed potential as a quantitative analysis tool, however it lagged 
behind the development of other optical devices such as MIR spectrometers, and many 
of its initial uses were as an accessory to these devices.  The US Dept. of Agriculture, 
under the work of Karl Norris, began to investigate the use of NIR in the measurement 
of moisture content in cereals.  Major difficulties existed such as interference and 
absorption of other constituents, and these were only resolved with the development of 
multivariate statistical methods which allowed the correlation of NIR spectral features.  
Following the introduction of such powerful computer aided tools; the first stand alone 
instrument became available in the early 1980’s.  Development of NIR spectroscopy as 
a quality and process control tool is largely due to the availability of efficient 
chemometric techniques and varying spectrometer configurations.13  Its use within the 
pharmaceutical/biopharmaceutical industry is fast growing, but it remains relatively 
new in terms of its status as a process analytical tool. 
 
Central to the development of NIR spectroscopy as a PAT tool is the availability of 
adequate sampling devices.  Process environments vary considerably and selecting the 
most appropriate sampling interface is of paramount importance.  A large degree of 
process understanding is vital prior to choosing the sampling interface.  The physical, 
chemical and optical nature of the process stream should be known in order to 
determine if the results will be significantly impacted by light scattering.  This is 
particularly important where NIR is concerned as the strong light source and the weak 
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absorbance allow infrared radiation to penetrate further into the sample, allowing 
particulates present in a suspension or slurry to cause light scattering.   Other aspects 
such as the potential of the process fluid to foul the probe or sample system should also 
be evaluated.9  Typically NIR sampling systems for in-situ process monitoring are in 
the form of one of the following two types:  extractive sampling systems, where the 
sample is removed from the main process line analysed and returned to the process or 
immersion probe sampling, where a probe is placed in the process stream of interest 
and a number of intermittent scans taken using fibre-optics to connect the analyser to 
the probe interface.  A number of variations of each of the above two types exist.  
Invariably, it is the process conditions which will dictate the system of choice.  
 
2.5  Development of Raman spectroscopy 
During the 1920s the scattering effect theory was investigated by a number of 
researchers including physicist C. V. Raman, who in 1928 was the first to 
experimentally demonstrate the Raman effect in liquids. 14  Originally instruments 
consisted of a mercury lamp passed through a filter to produce monochromatic light 
which was then used to excite the sample.  Scattered radiation was observed at 90o 
degrees from the incident radiation, dispersed using a glass prism and recorded on a 
photographic plate. 7  Such a system is known as dispersive Raman spectroscopy.  A 
modified FT-IR instrument was also used to collect Raman spectra and the use of such 
instruments is now known as FT-Raman spectroscopy.  Dispersive Raman 
spectroscopy and FT-Raman spectroscopy each have their own specific advantages 
and both continue to be used for different applications.7, 15     
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The basic components of any Raman spectrometer are the excitation source, the 
spectrometer and the detector. Significant advances in all three areas 16 have lead to the 
possibility of using Raman spectroscopy as a PAT tool. A major development in 
modern instruments was the incorporation of the laser as the monochromatic light 
source since the 1960s.  As such a small fraction of light is Raman scattered, a 
powerful excitation source is necessary and powerful laser light has led to the 
possibility of measuring smaller samples in a shorter amount of time.5, 7  Optical 
filtering devices are used to filter out a large portion of the Rayleigh scattered photons 
and so maximise the amount of Raman scattered photons which can be detected.  In 
the early 1990s holographic notch filters were introduced.   Their efficacy is due to the 
fact that the optical density of the notch filter is high and the spectral bandwidth of the 
notch can be extremely narrow. They are also free from extraneous reflection bands 
and provide significantly higher laser damage thresholds than standard interference 
filters.16, 17  Silicon based charged couple devices (CCD) are replacing 
photomultipliers as detectors in dispersive Raman instruments and this has allowed 
simultaneous measurement of multiple locations.  Detectors in FT-Raman instruments 
have also been improved.5, 18  Fibre-optics allow probes to be inserted directly into a 
reactor and cables up to 100 meters may be used to connect the instrument to the 
measurement point.  Non-contact sampling where a probe can make measurements 
through a sight glass is also possible.8  All of these advances mean that Raman 
spectroscopy has developed into a versatile PAT tool.  
 
2.6  Interpretation of spectral data using chemometrics 
It is almost impossible to discuss the use of spectral data without a discussion on 
concept of chemometrics as the various chemometric techniques maximise the 
  Chapter 2
   
 25 
 
information available from the spectroscopic instruments.  Chemometrics can be 
defined as the chemical discipline that uses mathematical, statistical and other methods 
employing formal logic (a) to design or select optimal measurement procedures and 
experiments, and (b) to provide maximum relevant chemical information by analysing 
chemical data.19  When applied to the spectra collected on-line during a bioprocess by 
MIR or NIR spectrometers, it is the second function of chemometrics that is of most 
interest.  Process data from a spectrometer is analysed in a multivariate rather than a 
univariate way, i.e. for each sample, the response at multiple wavenumbers are taken 
into account.  If the spectrum of a sample was recorded at three wavenumbers using 
any spectroscopic technique, a simple 2-dimensional plot of response versus 
wavenumber could be used to visualise the data. The same data can also represented 
by a single point in 3 dimensions where each dimension is corresponds to a 
wavenumber.  
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Fig. 2.5  Samples represented in 2-dimensional with the same samples represented 
by 1 point 3-dimensional space 
 
An individual spectrum recorded on a spectrometer can have hundreds of data points 
and a single component can have a response in multiple places within the one region 
making the data highly correlated.  Rather than representing the spectral data in 2-
dimensional space, chemometric techniques use multi-dimensional space or 
hyperspace to represent the same spectrum by a single point.  As there is usually much 
redundant information in spectra due to variables being highly correlated, data does 
not need to be represented in space with as many dimensions as there was original data 
points.  The spectral data containing hundreds of data points can be fully characterised 
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in as few as twenty dimensions.20  Chemometric or multivariate calibration techniques 
allow the concentration of a given analyte to be related to spectral features.  They are 
also useful for distinguishing real chemical information from instrument noise. 
 
2.6.1  Pre-treatments 
Prior to analysing spectral data, a mathematical pre-treatment may be necessary.  
Common pre-treatments include mean centering, mean normalisation and using the 
first or second derivative of the spectra.  To perform mean centring on a data set, the 
mean spectrum of the set is computed and then is subtracted from each spectrum in the 
set.  This is done to prevent data points that are further from the origin from exerting 
an undue amount of leverage over the points that are closer to the origin.20  Leverage is 
a measure of how extreme a data point is compared to the majority. A data point with 
high leverage will have a high influence on any model created.  Mean normalisation is 
an adjustment to a data set that equalizes the magnitude of each sample. When the 
spectra have been normalized, qualitative information that distinguishes one sample 
from another is retained but information that would separate two samples of identical 
composition but different concentration is removed.  A standard normal variate (SNV) 
pre-treatment is one which centres and scales individual spectra. The effect of this pre-
treatment is that on the vertical scale each spectrum is centred on zero and varies 
roughly from -2 to +2.  This effectively removes the multiplicative interferences of 
scatter and particle size in spectral data.21 
 
The first derivate of a spectrum is the slope of the curve at every point. It has peaks 
where the original has maximum slope and crosses zero where there was a peak in the 
original spectrum. As the slope is not affected by additive baseline offsets in the 
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spectrum; calculating the first derivative is an effective method of removing baseline 
effects. The second derivative is the slope of the first derivative. It has peaks in 
roughly the same places as the original spectrum but these peaks are in the inverted 
direction. Calculating the second derivative of a spectrum will remove additive 
baseline effects and as well as multiplicative baseline effect.22, 23  Small spectral 
differences are enhanced and overlapping peaks are separated by the use of derivative 
pre-treatments.  
 
As a measured spectrum is not a continuous mathematic curve, but rather a series of 
equally-spaced points, traditional derivative calculation performed by using the 
difference in values between two adjacent points has the effect of reducing the signal 
to noise ratio in the data.  It is necessary therefore to include some form of smoothing 
in the calculation.  One method of calculating the derivate of spectra is to use the 
algorithm described by Savitzky and Golay.24  This works by taking a narrow window 
centred at the wavelength of interest, and fitting a low order polynomial to the data 
points in this window using least squares.  The calculated polynomial is a continuous 
curve of the form y=a+bx+cx2...where x is the wavelength and y is the spectral 
response.  The first and second derivative of this fitted curve are then used as estimate 
of the derivatives of the underlying spectrum. 
 
The choice of pre-treatment can depend on the type of spectra being analysed e.g. NIR 
will often have derivative pre-treatments applied.25-27  A multi-component mixture or a 
sample collected on-line which may be subject to instrument drift will also be pre-
treated with a procedure such as SNV or derivatives.  Many other pre-treatments are 
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possible and the nature of the application will dictate the most suitable one or indeed 
combination to choose.  
 
2.6.2  Quantitative analysis 
Interpretation of spectra can be a challenge as many different components can have a 
response in similar regions of the electromagnetic spectrum.  This becomes an issue 
when you want to indentify and quantify individual components in a mixture. The first 
step in developing a calibration model is to do a simple feasibility study such as that 
described in the ASTM international standards28 for each component of interest.  The 
procedure described involves the collection of spectra from 30-50 samples 
incorporating the expected variations in particle size, sample presentation, and process 
conditions which are expected during analysis.  If the results from this simple study are 
favourable as judged by error values from cross validation methods and the precision 
required was obtained, the study can be expanded to see if multi-component mixtures 
can be adequately modelled.    
 
In order to make a good calibration model, a suitable experimental design must be 
employed.  The samples used for developing the model are known as the training or 
calibration set and should ideally comprise several uniformly distributed 
concentrations for each component of interest.  The factors in an experimental design 
for a multi-component mixture are the individual components and these factors should 
be mutually independent or orthogonal, i.e. the correlation coefficient between each 
pair of factors is zero.29 There has been some discussion in the literature on the 
importance of using uncorrelated samples in the development of chemometric models 
for on-line metabolite monitoring.30-33  As the performance of any model is directly 
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affected by the training set used in its development, the training set should fulfil 
certain criteria.  It should:  
• contain all expected components 
• span the concentration ranges of interest 
• span the conditions of interest 
• contain mutually independent samples 
The calibration should also be validated using a set of samples (validation set) which is 
independent of the training set.  Strategies on how to determine an experimental design 
which will achieve these aims can be found elsewhere.29, 34, 35 
 
2.6.3  Partial least squares regression 
An often used chemometric calibration technique for bioprocessing applications is 
partial least squares regression (PLS).  This is a multivariate statistical technique 
developed from classical least squares and inverse least squares regression by Swedish 
statistician Herman Wold for use in economic forecasting.  His son Svante Wold along 
with other Scandinavian scientists including Harold Martens promoted its use in 
chemical applications.34   
 
As mentioned earlier, spectra can be described by wavenumbers and responses in 2-
dimensional space or as single points in hyperspace.  In this way PLS works as a 
variable reduction system and new axes in hyperspace are computed using both the 
chemical and spectral data.  These new axes are computed in the direction of the most 
variance within the data and with PLS, the axis is the best compromise between the 
spectral variance and the concentration variance. 
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In an ideal case of noise free spectra, the factor space for the spectral data and the 
corresponding factor space for the concentration data are congruent i.e. the scores of 
the spectral data points are proportional to the corresponding eigenvector of the scores 
of the concentration data points. This relationship can be expressed by equation 2.3, 
where Yf is projection or score of a single concentration point onto the fth concentration 
factor, Xf is the score of a single spectral point onto the fth spectral factor and Bf is the 
proportionality constant for the fth pair of concentration and spectral factors.  
 
Yf=BfXf                                                                                              (2.3) 
 
 
The aim of PLS is to find a vector W that represents the best compromise between the 
spectral factor and the concentration factor. This vector is a factor that maximises the 
covariance between the concentration data matrix and all possible linear functions of the 
spectral data matrix. The factor W will have the same number of elements as there were 
wavelengths in the original spectra and the elements are called the loading weights. The 
first vector W1, is the most significant optimum factor and the portion of the variance in 
the spectral data spanned by this factor is removed as is the spanned variance in the 
concentration data. The next factor W2 is found for the spectral and concentration residuals 
that are not spanned by W1. The process is continued until all possible factors have been 
found.  The first new axis or factor is the most significant and accounts for the largest 
amount of variance in the spectral and concentration data.  A graphical representation 
of this can be seen in figure 2.6.20  
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Fig. 2.6  Graphical representation of PLS 
 
 
In physical terms PLS assumes that there are errors in both blocks which are of equal 
importance.  The concentrations used in a calibration model are subject to error (e.g. 
dilution and weighing) just as much as the spectra or chromatograms.  An important 
feature of PLS is that it is possible to determine how well the data have been modelled 
either by using x (spectral data) or y (concentration data) blocks. Fig. 2.7 illustrates 
the change in training set error as different numbers of components are calculated for 
both x and y in a typical dataset. This means that two different answers for the optimal 
number of components can be obtained, one based on the spectral data and the other 
based on the concentration data.34 
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Fig. 2.7 PLS training set errors using both the concentration and spectral estimates34 
 
2.7  PAT applications of vibrational spectroscopy in bioprocessing          
The applications or potential applications of vibrational spectroscopy in bioprocessing 
are largely dependent on the sampling interfaces available.  A number of instruments 
exist and sample interfaces vary from sample cavities using cuvettes or vials to 
immersion probes.  Where real-time data is required for monitoring and control 
purposes, the type of available instruments is very much reduced as all off-line 
techniques are eliminated.  Bioprocess applications to date have either used flow cells, 
where the sample of interest is passed through a measuring chamber, or immersion 
probes, where a probe is inserted into a reactor and the sample is scanned in-situ by 
transflectance, transmission or reflectance methods.  The development of high quality 
fibre-optics and autoclavable probes has increased the capabilities of these techniques.  
The most common applications in bioprocessing are analyte, metabolite and biomass 
monitoring, with monitoring systems in some cases further developed to enable 
process control.  
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2.7.1  MIR applications 
MIR lags behind its infrared counterpart, NIR, when it comes to its applications in 
bioprocessing.  Despite the fact that MIR can detect and quantify components in 
aqueous solutions at significantly lower levels than that of NIR,27 MIR is less 
extensively used.  Only in the last decade has MIR been considered a potentially useful 
tool for bioprocess monitoring.  Work to date has mainly focused on detection of 
substrates and metabolites in yeast and bacterial cultures but it has also been applied to 
suspended and immobilised animal cell cultures.36  Most methods use synthetic 
samples or samples taken from cell cultures to build multivariate models capable of 
predicting changing concentration values.  
 
The most common component modelled is glucose.  This is the predominant substrate 
in cell culturing and so, is of most interest from a detection and monitoring point of 
view.37-39  Other substrates detected using on-line MIR techniques include fructose, 
lactose, galactose, ammonia and methyl oleate. 40-42  Accuracy values vary between 
studies with standard prediction errors ranging from 0.26g/L to 0.86g/L for glucose.  
Subtle differences exist between the various techniques developed.  The sample 
presentation method is of some importance for this application as many cell cultures 
require aeration resulting in gas bubbles forming on the probe tip.  Automated flow 
systems can help mitigate this problem, while the recessed geometry of the probe tip 
can facilitate the formation of pockets on the crystal surface.27  In addition to the 
sampling interface, the models employed are specific to each individual set up.  
Although multivariate chemometric modelling is used to develop these models, each 
model is unique. 
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This technique has also been applied to determine the rate of product formation.  Cell 
culture products that have been successfully detected using MIR include ethanol, lactic 
acid and glucuronic acid.38, 39, 43   
 
On-line MIR measurements have been used not just to detect or monitor cell culture 
substrates and metabolites, but also to control cultures.  Kornmann et al used 
Gluconacetobactor xylinus to develop a control strategy based on the depletion of two 
substrates, fructose and ethanol.44   Real-time spectroscopic scans were collected every 
5 minutes, concentrations were sent to an adaptive control algorithm and fructose and 
ethanol were fed to the culture in controlled volumes.  Schenk et al showed that a 
similar system could be used to control methanol feeding to Pichia pastoris cultures.12 
 
 
2.7.2  NIR applications     
NIR spectroscopy can provide on-line information on substrate, biomass, product and 
metabolite concentrations.45, 46  This information can be further used to control and 
optimise cell cultures.  Extensive work has been carried out in this area to date.  NIR 
has been used to monitor concentration changes in yeast, bacterial and even 
mammalian cell cultures.  Crowley et al used NIR to monitor the main substrates, 
glycerol and methanol, as well as biomass, in a Pichia pastoris culture,46 Petersen et al 
used NIR to predict the changing concentrations of glucose, ammonium and biomass 
in a Streptomyces coelicolor culture,31 while Rodrigues et al developed an NIR model 
to monitor clavulanic acid, the product of a fed batch process with S. clavuligerus.47   
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The technique has also been applied to monitoring of mammalian cell cultures.  Four 
key analytes of a CHO-K1 mammalian cell culture, glucose, lactate, glutamine and 
ammonia, were monitored by Arnold et al. 48 and this work was further developed by 
Roychoudhury et al. 49 where a multiplexed calibration technique was used. 
 
As with MIR, NIR predictive models have also been applied to control systems in 
order to allow fed-batch cultures to react in “real time”.  As early as 1994 Vaccari et 
al. proposed using NIR to control the glucose feed in the production of lactic acid by 
Lactobacillus casei.50  Many others have developed control strategies for various yeast 
and microbial cultures. 51, 52 
 
2.7.3  Raman applications 
The reported use of Raman spectroscopy for monitoring bioprocesses in-situ and in 
real time is limited and this is most likely due to the need for low frequency lasers to 
avoid  fluorescence which can have heating effects due to the long exposure times 
necessary for such lasers.  Most reported studies describe the use of Raman 
spectroscopy to monitor yeast cultures.  One of the earliest applications of in-situ 
Raman spectroscopy was monitoring the production of ethanol in yeast 
fermentations.53  In this study the concentrations of fructose and glucose were also 
measured.  Shaw et al. used a dispersive Raman instrument to monitor the change in 
substrate and metabolite concentrations as well as product formation in yeast 
fermentation and found it necessary to include a by-pass filter to remove cells as they 
were causing interference to the photon scattering process.54  The production of 
carotenoids in Phaffia rhodozyma cultures has also been monitored by dispersive 
Raman spectroscopy.55  Bacterial cultures have also been monitored with in-situ 
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measurements of glucose, acetate, formate, lactate and phenylalanine being reported.56  
In a more recent study Raman spectra have been collected in-situ in a mammalian cell 
bioreactor.  As well as monitoring substrates and metabolites, the spectra were 
correlated to total cell density and viable cell density showing that it may be possible 
for Raman spectroscopy to distinguish between live and dead cells.57  While these 
studies all demonstrate the potential of Raman spectroscopy as a monitoring tool, it has 
yet to be proved capable of control in industrial bioprocesses.     
 
 
Although separate techniques, both MIR and NIR have similar applications in 
bioprocessing; both have been used for monitoring and control purposes.  Raman 
spectroscopy has been used to monitor bioprocesses but to a lesser degree than the 
other vibrational spectroscopies.  The manner in which these techniques are exploited 
is similar.  In all cases multivariate chemometric models are developed based on 
synthetic, semi-synthetic or actual samples from a cell culture.  Typically these models 
are then validated and applied to a culture on-line.  These techniques all have their 
benefits and limitations, but to date NIR has been the subject of more investigation and 
as a result is more developed in terms of applications in bioprocessing.  However, the 
potential of MIR and Raman should not be underestimated or overshadowed.        
 
2.8  Conclusions 
Choosing a suitable on-line analytical technique and data processing method for 
bioprocess applications is essential if reliable monitoring and control are to be 
achieved.  Each of the process analysers described here has the potential to be used for 
on-line measurement but it is only through proper understanding of their specific 
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advantages and limitations that they can be applied to monitor the appropriate process 
variables.  The relationship between the measureable parameters and critical process 
parameters needs to be recognised in order to develop calibrations for the critical 
process parameters of interest and knowledge of the likely signal interferences will 
allow the employment of data treatments which can minimise or even eliminate their 
effects.  Advanced data processing methods such as data reconciliation and artificial 
neural networks can also enhance the accuracy of the measured variables by using 
inputs from a number of on-line sensors.  The combination of suitable analytical 
techniques and data processing methods should provide an increase in bioprocess 
knowledge which will in turn allow the process to be tightly controlled and operate 
within a previously established design space. 
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Chapter 3 
Study 1:  Potential of Mid-infrared spectroscopy for on-line monitoring of 
mammalian cell culture medium components 
 
As published in Applied Spectroscopy, 2012, Vol. 66 (1), 33-39 
 
Abstract  
This study proposed a methodology to evaluate the potential of mid-infrared 
spectroscopy (MIR) as a process analytical technology (PAT) tool for in-situ (in-line) 
monitoring of cell culture media constituents, paving the way for on-line bioprocess 
monitoring and control of mammalian cell cultures.  The methodology included a limit 
of detection (LOD) analysis and external influence investigation in addition to the 
calibration model development.  The LOD analysis in the initial step provided a 
detailed procedure by which to evaluate the monitoring potential of the instrument of 
choice, for the application in question.  The external influence study highlighted the 
potential difficulties when applying this technique to a typical mammalian cell culture.  
   
A comparative investigation between a fixed conduit immersion probe and flexible 
fibre-optic immersion probe was also carried out.  Limitations associated with the use 
of MIR in the cell culture environment were also examined.  A preliminary 
investigation, on components typically found in mammalian cell cultures, involving 
spectral characterisation and limit of detection analysis was completed.  It was evident 
at this initial stage that glutamine, could not be accurately detected at levels typically 
found in a mammalian cell culture medium.  Results for glucose and ammonia, 
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however, proved promising.  A 7-concentration level experimental design was used, 
and partial least squares regression employed, to develop calibration models.  
Optimized model results echoed the results of the preliminary analysis with the 
percentage error of prediction for glucose as low as 6.03% with the fixed conduit 
probe, and glutamine having a higher error of 63.06% for the same probe.  Comparison 
of model results obtained from both probes supported the fixed conduit as the more 
accurate of the two probes, for this experimental set up.  The effect of external 
influences on the MIR spectra and hence the concentrations predicted by the model 
were also examined. These were subjected to statistical analysis to determine the 
significance of the effect.  This study demonstrates that MIR as a PAT tool, has limited 
potential for mammalian cell culture monitoring due to low concentrations of analytes 
present and outlines a method to allow the system to be evaluated.   
 
3.1  Introduction 
With increasing pressure from regulatory authorities on industry to develop processes 
embracing ‘Quality by Design’ initiatives, there is a growing demand to establish 
reliable tools and systems capable of meeting this need. 1, 2 With regard to monitoring 
and control of bioprocesses, this need translates to a search for robust instrumentation 
capable of monitoring the key process analytes and metabolites in real time.  Such 
information could potentially be used in the development of process control tools and 
hence would meet the fundamental principles of ‘Quality by Design’ and ‘Design 
Space’.3  Achieving on-line or real-time measurement and control allows for 
instantaneous analysis of the results and correction of offsets before the process moves 
outside of its design space.4  In a typical bioprocess a quantitative and qualitative 
analysis of all the major analytes in real time will provide vital information on the 
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process and facilitate the identification of key parameters capable of improving 
process outputs e.g. biomass, product secreted etc.5 The first step in developing such a 
system lies in the identification of a reliable monitoring technique, which could further 
be used as an integral part of an advanced control system.  
 
Infrared spectroscopy has the ability to monitor several of the analytes present in the 
culture media at any one time and as such is potentially a powerful tool in bioprocess 
monitoring.5-7  Such techniques can be used in-situ (in-line) making them non-invasive 
and eliminating the need for sample removal thereby reducing the risk of culture 
contamination due to possible compromised sterility.8  Sample preparation is not 
required and spectral information is obtained instantaneously.  These features make 
infrared techniques suitable for inclusion in control systems developed to function 
within a Process Analytical Technology (PAT) environment, an initiative proposed by 
the FDA in 20049 and further supported by the International Conference on 
Harmonisation10 in 2006.  The spectral data gleaned from such sensors must undergo 
some form of multivariate analysis in order to extract the desired information.11 With 
respect to the monitoring of bioprocesses, both the chemometric and infrared 
techniques serve as a lock and key to releasing bioprocess data.  Both near infrared 
(NIR) and mid infrared (MIR) spectroscopy have been used for bioprocess monitoring 
but with mammalian cell culturing, sterility is critical, so in-situ probes are 
preferable.12  In-situ sampling is possible with both techniques and is well documented 
for NIR,12-17  but less so for MIR spectroscopy, when applied to mammalian cell 
culture media components.18, 19  
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A preliminary step to developing a multi-analyte calibration model is to identify the 
instrument detection limits for each of the analytes under investigation.  The limit of 
detection (LOD) is the lowest concentration of analyte in a sample that can be detected 
but not necessarily quantified under the experimental conditions of the method.20 
Determining the LOD for a multivariate calibration is significantly more complex than 
establishing that of a univariate model.  To date, few studies have included this 
preliminary step in similar works despite its importance in an initial feasibility study.          
 
A number of external influences are likely to be present throughout the course of a cell 
culture.  The effect of these influences on the collected spectra and the media 
concentration values predicted by the model are of interest when considering the 
implementation of a calibration model in a monitoring or control application.  The 
significance of the impact of the external influence can be examined using hypothesis 
testing.  This can provide an insight into the effect of changing environmental factors 
on cell culture measurements using MIR.  It also highlights when and where influences 
should be incorporated into the model, so as to ensure optimum results.    
 
The aim of this work was to outline a method to examine the potential of MIR as a 
PAT tool to measure the varying media component concentrations of mammalian cell 
cultures in real time. This was achieved by developing a partial least squares (PLS) 
calibration model using synthetic samples, which ensure that the model remained 
generic and non-specific to any single bioprocess.  The methodology also included a 
logical sequence of preliminary steps, including a detailed limit of detection analysis, 
prior to the application of MIR to a mammalian cell culture.  In addition, two probe 
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types were used to determine the effect, if any, on results when the sampling device 
was varied, but the detector remained the same.   
 
3.2  Materials and Methods 
3.2.1  Samples 
Eight individual components made up of typical cell culture medium substrates, 
buffers and products of cell metabolism were examined.  These were, glucose (Sigma 
Aldrich Ireland Ltd.), L-glutamine (Sigma Aldrich Ireland Ltd.), HEPES (Sigma 
Aldrich Ireland Ltd.); glutamate, (Oxoid Ltd.); calcium lactate pentahydrate (Fisher 
Scientific UK); sodium hydrogen carbonate (Fisher Scientific UK); potassium 
phosphate (Sigma Aldrich Ireland Ltd.) and ammonium sulphate (Fisher Scientific 
U.K.).  Five of these (glucose, lactate, ammonia, glutamine and glutamate), are 
mammalian cell metabolites or by-products.  Such metabolites and by-products are 
likely to vary considerably throughout the course of a cell culture and therefore are of 
most interest from a monitoring and potentially, control, standpoint.  The remaining 
three elements, (HEPES, potassium phosphate and sodium hydrogen carbonate) are 
typically used to buffer a cell culture medium.  These do not vary considerably over 
the course of a cell culture; however they may vary over a range of different media.  In 
order to make the model generally applicable to a range of mammalian cell culture 
media these were included in its development.  Although the precise concentration of 
these buffers is not known for each commercial medium they tend to be present at high 
enough concentrations to impact the spectrum and so were included in the model.  
Other potential elements likely to be present in the media e.g. amino acids/vitamins are 
at lower concentrations and hence the impact on the spectrum and on the prediction 
ability of the model is minimal.  A cell culture medium, EX-CELL CHO DHFR− 
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Medium AF (Sigma Aldrich, Ireland Ltd.), was used in model validation steps and 
external influence investigation.  Table 3.1 outlines the concentration ranges used for 
model development for each of the 8 components selected. 
 
Table 3.1 Component concentration ranges 
Component Concentration Range 
g/L 
Glucose 0-6 
Lactate 0-1 
Ammonia 0-1 
Glutamine 0-0.6 
Glutamate 0-0.7 
Phosphate 0-1 
Sodium Bicarbonate 0-1.25 
HEPES 0-4.5 
  
 
3.2.2  Instrumentation 
All scans were taken using a Fourier transform mid-infrared ReactIR iC10 instrument 
with MCT detector (Mettler Toledo AutoChem, Inc., Columbia, US).  Two immersion 
probes were tested in all cases (i) AgX 9.5mm x 2m fibre silver halide probe and (ii) 
K6 conduit 16 mm probe, both of which have a fixed optical pathlength of approx. 1 – 
2 µm and use a diamond ATR crystal with 6 internal reflections.  Fig. 3.1 shows both 
probe types.  The sampling procedure was as follows:   a background scan of deionised 
water at 37oC was taken followed by 3 replicates of 128 co-added scans of each 
sample also at 37oC as this temperature is optimum for mammalian cell growth.  
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(i)        (ii) 
Fig. 3.1 (i) Flexible Fibre-Optic and (ii) Fixed Conduit Probes 
 
 
3.2.3  Preliminary analysis 
Concentrated solutions of each of the 8 main components were made up using 
deionised water.  The spectra for each component were collected and then plotted.  The 
wavenumber ranges over which each of the components absorbed was noted, to be 
later used in the development of the calibration model.  Fig. 3.2 shows the raw spectra 
of the 8 components modelled and indicates their main regions of absorbance.    
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Fig. 3.2 Raw spectra of the 8 matrix components over the usable spectral regions  
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The concentrated stock solutions described above were used to prepare a series of 
dilute solutions. These were then scanned in triplicate, with the K6 conduit probe and 
the collected spectra plotted and examined.  This allowed for a preliminary 
investigation into the presence of outliers and also an investigation into the LOD based 
on a simple visual test.  The point where the component peaks could not be clearly 
distinguished from the instrument noise was defined as the observed LOD.  This is 
only possible for MIR spectroscopy as it is based on fundamental vibrations and the 
peaks can be directly related to a chemical bond but such a step could not be done for 
NIR spectroscopy.  Fig. 3.3 below indicates how peak height increases with increasing 
concentration.    
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Fig. 3.3 Glucose spectra at varying concentrations 
 
As multivariate analysis techniques are usually necessary to fully exploit vibrational 
spectroscopy data, a method for determination of LOD for multivariate spectral data is 
needed.  Unfortunately there is no generally accepted method for this but an approach 
used by many authors is to transform the multivariate data to univariate data by the use 
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of chemometric techniques21 such as PLS regression.22 The method outlined by Ortiz 
et al23, 24 is used here.  It allows for the assessment of the LOD of an analytical method 
by evaluating false positive and false negative probabilities after data has been 
transformed by PLS.  The false positive probability follows a Student’s t-distribution 
with (n-2) degrees of freedom where n is the number of samples while the false 
negative probability has a non-central Student’s t-distribution with (n-2) degrees of 
freedom and a parameter of non-centrality which needs to be established. Critical 
values for both types of Student’s t-tests and the parameter of non-centrality were 
determined using the statistical toolbox in MATLAB (v7.9.0.529 (R2009b), The 
MathWorks Inc., Cambridge, UK).   Development of PLS models was carried out 
using the PLS toolbox (V6.2 Eigenvector Research Inc, Washington, US) for 
MATLAB.  In all cases the spectral data were mean centered and first and second 
derivative pre-treatments using a segment size of 15 points were calculated using 
quadratic Savitzky-Golay25 filters.  Statistical analysis was applied to the regression 
between actual concentration values and those predicted by leave-one-out cross 
validation. 
 
3.2.4  Calibration model development 
In order to develop a robust reliable model for a multivariate calibration, several 
concentrations are necessary, which require all possible combinations of levels for all 
the factors, i.e. a full factorial multilevel design.  This is impractical as it would result 
in a huge number of samples, therefore, for this calibration model, a partial factorial 
design for a multivariate calibration was employed.  A 7 concentration-level 
experimental design was chosen, which accounts for the orthogonality between 
successive factors.  This resulted in the generation of 49 samples, each containing 
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varying concentrations of the 8 components.26   Concentrated solutions of the 8 
components were made and based on the experimental design, specified units of each 
solution were used to create each of the 49 samples.  The concentration of each bulk 
solution was such that it reached the expected maximum concentration of that 
component in a typical cell culture medium.  The purpose of this was to ensure that the 
calibration model under development catered for the entire concentration range of each 
of the 8 components in the medium, but at the same time did not compromise the 
accuracy of the model by using too wide a concentration range in its development.  
Each of the 49 samples was scanned with both probe types.   
 
The spectral data were exported from the iCIR software (Mettler Toledo AutoChem, 
Inc., Columbia, US) and imported into MATLAB.  Mean values of the triplicate scans 
were used for model development.  Pre-processing in the form of mean-centering was 
initially applied to all spectra.  A second derivative pre-treatment using a segment size 
of 15 points was also examined as second derivative pre-treatments can eliminate the 
effect of linear baseline spectral off-sets27 that are likely to occur over the course of a 
culture.  Partial least squares regression, optimized by leave-one-out cross-validation, 
was used to develop separate calibration models for each of the 8 components.   
    
The calibration model was validated in two ways.  Firstly, a 4-level multivariate design 
was employed.  This was similar to the 7-level design used for the creation of the 
model, however only 16 samples of varying concentration were generated.  There are a 
number of suggested validation methods in use but the “Rule of 3” is widely accepted 
as a suitable technique for evaluating the accuracy of a model.22  This rule proposes 
that the calibration set be 3 times larger than the validation set.  In this case the 
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calibration set, a 7-level design, resulted in the generation of 49 samples, therefore, the 
4-level design, resulting in a sample set of 16 samples and almost one third the size, 
was chosen to validate the models.  Each of these 16 samples was scanned with both 
probes as before.  The spectral data resulting from these scans was then inputted into 
the model and the component concentrations in each of the 16 samples were predicted 
by the model.  These predicted values were then compared to the actual values.  
Secondly the cell culture medium was spiked with known concentrations of different 
components and the model was used to predict the resulting increase in concentration.  
The results of all models were evaluated by the root mean square errors of calibration, 
cross validation and prediction (RMSEC, RMSECV and RMSEP) as well as the LOD 
for a multicomponent mixture. 
 
3.2.5  External influence investigation 
In order to establish if the model would accurately predict cell culture concentrations 
when exposed to the conditions typically found in a cell culture environment, a series 
of experiments were carried out.  The effect of varying temperature, agitation, 
biomass, and pH were investigated.  In addition, the presence or lack of antifoam and 
pluronic was also examined.  For each external influence examined, a background of 
water was initially scanned within a bioreactor; the bioreactor was then drained and 
dried and filled with EX-CELL CHO DHFR− medium.  The bioreactor environment 
was varied as outlined in Table 3.2.  Both the agitation and temperature were varied by 
adjusting the appropriate settings on the reactor control system.  The pH of the media 
was varied by the addition of hydrochloric acid and sodium hydroxide to create acidic 
and alkaline conditions respectively.  The biomass was altered by simulating the 
growth of a cell culture during the exponential growth phase; with the cumulative 
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addition of a fixed cell density over time.  Each variation in bioreactor conditions was 
scanned in triplicate using 128 co-added scans.  These scans were ratioed against the 
initial background of deionised water.   
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TABLE 3.2  External influence investigation summary  
Exp. 
#  
Temperature 
(oC) 
pH 
(-) 
Agitation 
(rpm) 
Biomass 
(cells/ml) 
Antifoam 
(% v/v) 
Pluronic 
(g/L) 
1 30 – 44 ± 0.2  7.9 150  - - - 
2 37 ± 0.2  5 - 10 150  - - - 
3 37 ± 0.2  7.9 40 - 400 - - - 
4 37 ± 0.2  7.9 150  0 - 4.5x106 - - 
5 37 ± 0.2  7.9 150  - 0.05 - 
6 37 ± 0.2  7.9 150  - - 0.1 
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PLS regression was the multivariate technique employed to assess the effect of an 
influence when the influence was varied (temperature, pH, agitation, and biomass) and 
PLS-DA (Partial least squares discriminant analysis)28 was the multivariate method 
used for examination if an influence impacted the spectra when present (antifoam and 
pluronic). The data was subjected to two tests, a spectral test and a relevance test.  The 
spectral test involved the data undergoing a multivariate transformation followed by 
hypothesis testing.  The relevance test examined the effect (if any), on the predicted 
glucose concentration values.  Pre-treatments in the form of mean centering followed 
by second derivative using the Savitzky-Golay method were applied to all spectra prior 
to modeling, and in all cases, cross validation was used to optimize the models.  
 
A PLS model was constructed to determine whether there was a relationship between 
the spectra and the external influence variables, temperature, pH, agitation, and 
biomass.  Plots of predicted magnitude of influence applied versus actual values for 
each of the tests yielded the coefficient of determination (r2) and hence the correlation 
coefficient (r) was calculated.  Based on a Student’s t-test, Pearson’s correlation29 was 
used to test the significance between the influence and the spectral measurement. The 
null hypothesis (H0) was that the influence had no effect on the spectra. Where t>tcritical 
at a significance level (α) of 0.05, H0 was rejected and this implied that the external 
influence under investigation had a significant effect on the spectra.   Where t<tcritical at 
α=0.05, H0 was accepted and this implied that the external influence under 
investigation did not have a significant effect on the spectra. 
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The same statistical test was employed when determining the relevance of the impact 
of each influence on the predicted glucose concentration values.  In this case, the 
optimum PLS model for glucose, established in the calibration model development 
section, was used to predict the glucose concentration.  A plot of magnitude of external 
influence versus predicted glucose concentration provided r2 values for each of the 
external influences, and as before, a Student’s t-test was used to establish if the 
influence had a significant impact on the predicted glucose concentration values at 
α=0.05. 
 
Multivariate discriminant analysis was used for tests involving antifoam and pluronic 
as these were not varied.  In both cases concentrations typically used in cell culture 
media were added.  A PLS-DA model was used to transform the data with respect to 
the presence or lack of influence applied.  A Student’s t-test was used to interpret the 
results of the PLS-DA and determine the significance of the effect of both antifoam 
and pluronic on the spectra.  In this case, H0 was that all samples were the same and 
the alternative hypothesis (Ha) was that samples with the influence applied were 
different.  The same hypothesis test was also applied to the predicted glucose 
concentrations for the same sample set. 
All experiments were carried out using both the AgX 9.5mm x 2m fibre silver halide 
probe (flexible) and the K6 conduit 16 mm probe (fixed).         
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3.3  Results and Discussion 
3.3.1  Preliminary analysis 
The spectrum of commercial media exhibited a number of peaks.  The region of 
highest absorbance (1250 – 1000 cm-1) is as a result of the overlapping absorbances of 
the constituent components.  This highlighted the problems associated with attributing 
the absorbance to a particular component given the overlapping nature of the pure 
component spectra.     
  
The spectra of concentrated solutions of each of the pure components were examined 
to determine the wavenumber ranges over which absorbance occurs.  Concentrated 
stock solutions, within the water solubility limits of each of the components were used 
as all absorbance features may not be clearly evident in dilute solutions.  The 
wavenumber ranges established at this stage are shown in Table 3.3.  These were used 
when developing and applying the calibration model.  This ensured that the predictions 
were based on the underlying chemical principle and not metabolism induced 
correlations.19, 30 
 
The observed LOD for all components can be found in Table 3.3 alongside the LOD 
determined using a PLS model which has been subjected to hypothesis testing 
ensuring false positive and false negative probabilities of 0.05.  The PLS model details 
used in the calculation of these LODs have also been included in Table 3.3.  The 
observed and calculated LODs differ by an order of magnitude for all components with 
the exception of glutamine and glutamate which differ by a factor of 4.  This shows 
that a visual inspection is not sufficient to determine such a parameter and more 
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information can be gleaned using a chemometric technique which is as expected for a 
multivariate data set.  Glucose, ammonia, phosphate, lactate, HEPES and bicarbonate 
could all be detected to levels of 0.09 g/L or lower. Glutamine and glutamate were not 
detected to as low a level as the other components.  This is most likely due to the fact 
that the molecular bonds present in these components tend to have weak absorbances 
in the MIR region detectable with the instrument used in this study.31 These LOD 
values are based on pure component solutions and are only applicable to single 
component measurements.  This is a simple feasibility study and it establishes at an 
early stage the ability of the MIR instrument to measure the components at the low 
levels found in mammalian cell cultures. 
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TABLE 3.3  Preliminary analysis results 
Component 
Wavenumber 
Range (cm-1) 
Pre-treatment 
 
# LVs 
Calculated LOD 
(g/L) 
Observed LOD 
(g/L) 
Glucose 950-1450 Mean centered 5 
0.09 
 
1.0 
Glutamine 950-1700 Mean centered, 1st derivative 6 
0.30 
 
1.2 
Ammonia 950-1500 Mean centered, 1st derivative 2 
0.01 
 
0.1 
Phosphate 900-1320 Mean centered 5 
0.03 
 
0.3 
Glutamate 900-1760 Mean centered 5 
0.35 
 
1.3 
Lactate 1000-1620 Mean centered 6 
0.03 
 
0.5 
HEPES 1000-1250 Mean centered, 1st derivative 6 
0.05 
 
0.6 
Bicarbonate 960-1750 Mean centered, 1st derivative 2 
0.06 
 
0.5 
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3.3.2  Calibration model development and validation 
As stated previously, calibration model development was completed using both probes, 
the K6 conduit fixed probe and the flexible fibre-optic probe.  The detector used in 
both cases was the same.  Previous studies have used fixed conduit ATR probes18, 32 
and discussed the importance of alignment of such probes as well as spectral 
differences which can occur when the alignment is changed.33-35  The development of 
infrared fibre-optic immersion probes is relatively new,13 in particular for mid-infrared 
probes;36 hence the evaluation of such a probe for the monitoring of mammalian cell 
culture media components is quite relevant.   The fibre-optic configuration should 
eliminate the alignment issues inherent in the fixed conduit configuration.    
 
The results obtained using both probe types varied considerably and as the 
experimental design and detector were unchanged, a comparison between both probes 
was carried out in an attempt to establish possible causes for the differing results.  The 
MIR range is generally considered to lie between 4000-400 cm-1.  Both probes have a 
reduced effective range due to absorbance of the diamond ATR crystal over the range 
of 2250-1950 cm-1.  In addition the fibre-optics of the flexible probe themselves absorb 
infrared radiation, further reducing the effective range of this probe to wavenumbers 
less than 1950 cm-1.  While the K6 conduit fixed probe measured absorbance between 
4000-2250 cm-1, spectra in this region were extremely noisy and therefore unusable.  
At lower wavenumbers and also, close to the ATR absorbance region, the spectra 
exhibited a large degree of noise, so this meant that the two probes under investigation 
had the same usable wavenumber range (1800-900 cm-1) therefore any discrepancies in 
results between the two probes cannot be attributed to differing wavenumber ranges.   
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The most significant difference between both probes is the geometry of the probe tip.  
The K6 conduit probe contains a recessed diamond crystal.  The outer probe casing 
forms a gradual slope to the ATR crystal, thus allowing for shearing of bubbles, which 
may adhere to the crystal surface.  The silver halide fibre-optic probe also contains a 
recessed diamond crystal, however in this case the outer casing does not form a 
gradual slope, but rather the crystal is set at a 90o angle to the casing and hence a 
“pocket” at the probe tip allows for the entrapment of bubbles.  Removing bubbles 
from the tip of this probe proves more difficult as the shear forces at the probe tip do 
not reach the bubble trapped inside.  In addition, the high surface tension of water 
results in bubbles in aqueous solutions adhering to the probe tip,21 making this 
application (to an aqueous based cell culture media), more problematic than typical 
applications in reaction chemistry.  Fig. 3.4 shows the problems encountered with 
bubble entrapment.  
 
 
Fig. 3.4 Air bubble on probe tip 
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Calibration model results for all samples are shown in Table 3.4.  These models are 
based on calibration samples which contain varying amounts of all 8 components of 
interest.  In the majority of cases, the RMSEC values are lower for the K6 conduit 
probe than those for the silver halide fibre-optic probe.  All the RMSEC values are less 
than 0.25 g/L, and in the case of ammonia, it was as low as 0.02 g/L.  Different 
concentrations of each of the 8 components were used, corresponding to typical values 
in cell culture media.  In order to put the RMSEC in perspective, a percentage error of 
calibration (PEC) was calculated for each of the models, by dividing the RMSEC by 
the average concentration used in the calibration.  While the RMSEC for glutamate 
and glutamine appear quite low for both probes, they represent quite high percentage 
errors, indicating that problems are likely with the prediction ability of the glutamate 
and glutamine models.  The percentage errors of cross validation and prediction, 
(PECV and PEP), calculated in a similar manner to the PEC, were greater than 60% 
for glutamate and glutamine, thereby indicating that the predicted concentrations of 
glutamate and glutamine are not reliable.  This supports the results of the preliminary 
analysis, where the LODs were higher than those of the other components and close to 
the maximum concentrations typically found in a cell culture environment.  Based on 
this information, these components models were not further validated using the spiking 
test.                    
 
All other components had lower percentage errors than glutamine and glutamate with 
glucose and ammonia showing the lowest percentage errors of approximately 15% or 
less regardless of probe type or validation set used (Table 3.5).  A plot of predicted 
glucose concentration versus actual glucose concentration as measured with the K6 
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conduit probe can be seen in Fig. 3.5.   This model had low percentage errors and it 
can be seen that all samples lie close to the 1:1 calibration line.  
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TABLE 3.4  Calibration model results 
Component Probe # LVs RMSEC PEC RMSECV PECV 
Glucose K6 conduit 4 0.25 8.64 0.34 11.65 
 
Fibre-optic 5 0.31 10.38 0.44 14.81 
Glutamine K6 conduit 12 0.02 7.48 0.24 77.24 
 
Fibre-optic 3 0.12 40.07 0.25 82.89 
Ammonia K6 conduit 3 0.02 4.49 0.03 5.91 
 
Fibre-optic 4 0.03 5.04 0.04 7.16 
Phosphate K6 conduit 4 0.14 30.38 0.19 40.60 
 
Fibre-optic 5 0.11 24.28 0.15 32.82 
Glutamate K6 conduit 6 0.09 26.43 0.22 62.88 
 
Fibre-optic 3 0.12 35.39 0.27 77.68 
Lactate K6 conduit 4 0.04 9.30 0.06 13.84 
 
Fibre-optic 3 0.20 45.37 0.24 54.60 
HEPES K6 conduit 4 0.21 9.94 0.29 13.86 
 
Fibre-optic 4 0.21 10.23 0.27 13.05 
Bicarbonate K6 conduit 8 0.07 12.25 0.23 37.26 
 
Fibre-optic 5 0.12 19.05 0.31 51.39 
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TABLE 3.5  Validation results 
Component Probe RMSEP 
matrix 
PEP 
matrix 
RMSEP 
spiked 
PEP 
spiked LOD 
Glucose K6 conduit 0.17 6.03 0.41 13.53 0.41 
 
Fibre-optic 0.35 
 
12.42 
 
0.24 
 
15.40 
 
 
0.80 
 
Glutamine K6 conduit 
 
0.19 
 
 
63.06 
 
- - 
 
1.31 
 
 
Fibre-optic 
 
0.31 
 
 
104.25 
 
- - 
 
5.58 
 
Ammonia K6 conduit 
 
0.06 
 
 
13.17 
 
 
0.09 
 
 
16.14 
 
 
0.14 
 
 
Fibre-optic 
 
0.06 
 
 
11.53 
 
 
0.10 
 
 
18.23 
 
 
0.12 
 
Phosphate K6 conduit 
 
0.14 
 
 
31.58 
 
 
0.07 
 
 
10.49 
 
 
0.33 
 
 
Fibre-optic 
 
0.18 
 
 
41.85 
 
 
0.07 
 
 
10.57 
 
 
0.45 
 
Glutamate K6 conduit 
 
0.21 
 
 
64.45 
 
- - 
 
0.67 
 
 
Fibre-optic 
 
0.32 
 
 
96.93 
 
- - 
 
1.93 
 
Lactate K6 conduit 
 
0.07 
 
 
16.77 
 
 
0.32 
 
 
78.56 
 
 
0.16 
 
 
Fibre-optic 0.13 30.81 0.18 44.69 0.28 
HEPES K6 conduit 0.30 14.97 0.08 8.26 0.71 
 
Fibre-optic 0.26 12.91 0.49 48.47 0.66 
Bicarbonate K6 conduit 0.37 45.72 0.60 24.49 1.64 
 
Fibre-optic 0.52 64.76 0.72 30.13 2.68 
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Fig. 3.5  Plot of predicted versus actual glucose concentrations for calibration and 
validation data, as measured with K6 conduit probe 
 
 
Table 3.6 provides a summary of literature examples of infrared spectroscopy 
instruments with different types of sampling being used to measure glucose 
concentration; with glucose being the most common metabolite measured in 
bioprocesses.  For the sake of comparison with the results in this study, any values 
reported as mM were converted to g/L and reduced to 2 significant figures. 
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   TABLE 3.6   Infrared spectroscopy instruments being used to measure glucose in bioprocesses 
Technique Sampling Accessory Culture type #Cal #Val RMSEC RMSECV RMSEP % error Ref. 
     g/L g/L g/L   
NIR Off-line Transmission Mammalian 58 14 0.60  0.53  
37
 
NIR Off-line Transmission Mammalian   0.04  0.07 1.86 38 
NIR In-line Transmission/Fibre optic  104 24 0.10  0.15 3.98 14 
NIR In-line Reflectance/Fibre optic Bacteria 80 30 1.79 4.70 2.90  13 
NIR In-line Transmission/Fibre optic Mammalian 217  0.13 0.07 0.10  12 
NIR On-line Transmission Mammalian     0.17  39 
NIR-Vis Off-line Transmission Yeast 126 70 0.79  0.80  40 
NIR In-line Transflectance/Fibre optic Mammalian 50 16 0.10  0.20  15 
NIR In-line Transflectance/Fibre optic Bacteria    1.90 2.00 9.70 16 
NIR In-line Transflectance/Fibre optic Mammalian    0.23 0.19  17 
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Technique Sampling Accessory Culture type #Cal #Val RMSEC RMSECV RMSEP % error Ref. 
     g/L g/L g/L   
NIR In-line Transflectance/Fibre optic Mammalian 73 12 0.30 0.36 0.36  30 
MIR In-line ATR/Fibre optic Bacteria   2.80  3.50  36 
MIR In-line ATR/Conduit Bacteria 91   0.26   32 
MIR In-line ATR Mammalian 60 225 0.09  0.11  18 
MIR Off-line Transmission Yeast/Bacteria    0.38   41 
MIR On-line ATR Yeast   0.35 0.40 0.27  42 
MIR Off-line HATR Bacteria 70 20 0.69  0.56  43 
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When results from this study are compared to those listed in Table 3.6, it can be seen 
that the RMSEC values are of the same order of magnitude but without a percentage 
error value, it is not always appropriate to compare these.  The most comparable study 
was that of Rhiel et al,18 where an RMSEC value of 0.09 g/L was obtained.  While this 
value is lower than that achieved in this study, models were developed with a larger 
number of calibration samples which could improve the error values.  As stated 
previously, an experimental design requiring a minimal number of samples (49) was 
used in this study.26  When the model was applied to the validation matrix samples, 
phosphate, lactate, and bicarbonate all had lower errors when the K6 conduit probe 
was used.   The errors for HEPES were lower for the fibre-optic probe but only by a 
small amount.  Samples of media spiked with known amounts of a given component 
represent a slightly more difficult test for the model as these samples had unknown 
components present as the exact composition of the commercial medium used was not 
known.  Spiked sample PEPs for glucose, ammonia and lactate were all higher than for 
the validation matrix samples.  The results for the other components did not give 
consistent results for the different validation sets.   Of the 9 studies with in-situ probes 
in Table 3.6, only 3 of these achieve a lower RMSEP than that reported in this study 
but as stated above, a direct comparison is not always possible without details on the 
percentage error. 
 
In a similar way to the calibration models of single components in the preliminary 
analysis section, the models made from multicomponent samples were subjected to the 
same hypothesis test to determine an LOD with a false positive and false negative 
probability of 0.05.  Every component had a higher LOD value in a multicomponent 
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mixture than that calculated using single components samples.  In almost all cases the 
value was an order of magnitude higher and for glutamine, glutamate and bicarbonate, 
the LOD value was larger than the maximum concentration of each component that 
was used to make the calibration samples.  
 
3.3.3  External Influence investigation 
The results of the external influence tests can be seen in Table 3.7.  In all cases of the 
agitation test, H0 was accepted, strongly suggesting that variation in impeller speed had 
little effect on the spectra and hence the predicted concentration of the model.  
Hypothesis testing of the antifoam results indicated that the presence of antifoam did 
not appear to impact the spectra significantly; therefore it is not necessary to account 
for this when developing a calibration model. 
 
Based on the results of the statistical tests applied to variation in pH, as expected, H0 
was rejected both for the spectral test and the relevance test, for both probes.  Varying 
pH changes the chemical constitution of the media and based on the underlying 
principle of infrared spectroscopy,33 it follows that the spectra will also change.  The 
cell culture environment requires tight control of the pH; therefore major shifts in pH, 
resulting in inaccurately predicted values are unlikely to occur.  However, for the 
development of a calibration model where the system is likely to experience pH 
changes, pH should be used as an additional factor in the experimental design.   
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TABLE 3.7  Hypothesis test results for external influences 
  Agitation Biomass pH Temperature  Antifoam Pluronic 
Fibre optic accept Ho reject Ho reject Ho reject Ho  accept Ho reject Ho Multivariate  
test K6 conduit accept Ho reject Ho reject Ho reject Ho  accept Ho reject Ho 
         
Fibre optic accept Ho accept Ho reject Ho reject Ho  accept Ho reject Ho Relevance  
test K6 conduit accept Ho reject Ho reject Ho reject Ho  accept Ho accept Ho 
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Statistical analysis of biomass concentration indicates that the spectra and hence the 
predicted concentration values will change as the biomass concentration increases.  By 
simulating the growth of a cell culture the sample media could possibly have been 
altered with the addition of small amounts of spent media in which the cells were 
suspended prior to addition.    This potential change which would not occur over the 
course of an actual cell culture could have been confounded with the effect of the 
increasing biomass concentration.  The relevance test indicated that this is not a 
significant result for the fibre optic probe while for the K6 conduit probe it was 
calculated to be significant at α=0.05. Previous studies have shown that biomass 
concentration can have an effect on NIR spectra due to light scatter and the fact that 
biomass absorbs in the NIR region.14, 16  The ATR sample method for MIR instruments 
results in a short penetration depth of the MIR light source44, 45 so scatter effects will 
not be present.36  
 
The effect of varying temperature was calculated to have a significant effect for both 
the spectral and relevance tests, for both probes.  This is not unexpected as temperature 
impacts the bonds between the molecules which is the underlying principle of 
vibrational spectroscopy including MIR.46   As with pH, temperature is tightly 
controlled in mammalian cell cultures so unless deliberate temperature shifts are 
necessary, this factor does not need to be accounted for in the model.  If the same 
model was to be applied to a cell culture with identical parameters with the exception 
of temperature, it would need to be recalibrated accounting for the temperature change 
by including temperature as a factor in the experimental design. 
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Pluronic can sometimes be added to mammalian cell cultures and the effect of addition 
at typical concentrations appears to have a significant effect on a spectral level. This 
result was  
 
found using both probes.  The relevance test indicated that it was not significant for the 
K6 conduit probe but that it was a significant effect for the fibre-optic probe.  Given 
this difference, it would be recommended that if pluronic is to be added to a cell 
culture, it should be included in the experimental stage.  This would not be difficult to 
do as it would be present at the same concentration in each sample. 
 
3.4  Conclusion  
This study outlines a methodology for evaluating the potential of mid-infrared 
spectroscopy as an on-line tool for monitoring mammalian cell culture media 
constituents.  This method is beneficial as it identifies at an early stage where the 
technique may be best applied.  A detailed comparison of two sampling systems is also 
outlined.  This highlights any issues due to differing design of ‘sample to crystal’ 
interface areas.   The importance of a chemometric technique, in the treatment of the 
data for the LOD analysis, is clearly evident as the observed LOD was always found to 
be greater than the calculated LOD.  The LOD results indicate that at concentration 
levels found in cell cultures, certain components e.g. glutamine, lie below the detection 
ability of the instrument.  Also, the LOD for each component is significantly higher in 
the multicomponent mixture than in the single component mixture.            
 
An experimental design using a sample set of 49 and concentrations typically found in 
a mammalian cell culture were used in the development of the calibration models.   
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The study indicates the applicability of the technique in the monitoring of glucose and 
ammonia, both of which are major media constituents in mammalian cell cultures.  
Although all 8 components investigated cannot be reliably monitored, due to their 
presence at such low concentration levels, there is potential for the development of a 
control platform, of a mammalian cell  
 
culture, based on glucose and ammonia.  It should be noted that the accuracy of the 
prediction ability of a model is very much dependent on the sample set size and the 
concentration level of each of the components present.   An increase in the number of 
samples in the sample set should improve the accuracy of the model.   
 
Finally the external influence series of experiments indicate that changes in certain 
environmental conditions will impact spectra.  However is must be noted that 
maintaining these environmental conditions relatively constant is crucial to the overall 
bioprocess.  Therefore changes will impact results, however, the range over which 
these changes can occur, without impacting the bioprocess is so tight that the process 
will be affected before the spectra are impacted. 
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Chapter 4 
Study 2:  Application and optimisation of in-situ MIR calibration models for the 
prediction of glucose and lactate in mammalian cell cultures 
 
As submitted to Applied Spectroscopy, January 2013 
 
Abstract 
The primary aim of this study was to apply multivariate calibration models to data 
collected in real time during the course of a CHO DP12 cell culture in bioreactors to 
predict glucose and lactate concentrations.  To achieve this aim, an investigation into 
the optimisation of these models was performed in an effort to improve their accuracy 
and robustness.  The study comprised a series of 3 cultures which were monitored in-
situ using mid-infrared (MIR) spectroscopy.  Samples for reference HPLC analysis 
were taken daily to compare to the in-situ MIR predicted data.  Aliquots of these daily 
samples were scanned using the same instrument once all cultures were complete and 
the same partial least squares regression (PLS) models applied in order to evaluate the 
set- up when applied in an offline or at-line scenario.  The PLS models used exhibited 
expected trends when applied in-situ, with glucose depletion and lactate formation 
clearly evident.  The accuracy of prediction however was low, with RMSEP values for 
glucose and lactate, 0.73g/L and 1.21g/L respectively.  When the same models were 
applied to the spectra of culture samples taken offline the glucose and lactate errors 
were reduced by 60.27 and 13.22% respectively.  Optimisation of glucose and lactate 
models for in-situ use was achieved by developing PLS models using spectral data 
generated in-situ and offline from all 3 cell cultures.  When offline data was used as 
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part of the optimised calibration training set, such models consistently performed 
better than the original PLS models.  Optimised glucose model results showed an 
improvement in RMSEP as high as 37.93% while optimised lactate model results had 
an improved RMSEP of 61.98%.       
    
4.1  Introduction 
Over a decade since its conception in August 2002, the Food and Drug 
Administration’s (FDA) initiative, “Pharmaceutical Current Good Manufacturing 
Practices”, (cGMP’s), has had a significant impact on the pharmaceutical and 
biopharmaceutical industries.1-3  The purpose of this initiative is to modernise the 
regulation of pharmaceutical quality through the support and promotion of risk-based 
and science-based approaches.4  Central to the implementation of this initiative is the 
concept of Quality by Design (QbD) which utilises Process Analytical Technologies 
(PAT) to gain in-depth process understanding, leading to the eventual application of 
these technologies to monitor and control processes, thus mitigating risk and reducing 
variability.5    
 
Quantitative analysis of the key analytes and metabolites in a bioprocess can provide a 
plethora of information, which, when applied, can yield powerful results such as 
improved product quality and enhanced biomass production.6  PAT tools should be 
capable of providing rapid yet reliable measurements, be possible to calibrate and 
preferably be non-invasive.  Infrared (IR) spectroscopy meets these criteria and has 
been shown to monitor key analytes both in-situ and at-line.6-8  Development of 
chemometric models for quantitative measurement of cell culture components via IR 
has been documented, with the greater portion of this work focused on the use of near-
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infrared (NIR) spectroscopy.9-14  The development of such models using mid-infrared 
(MIR) spectroscopy has also been reported, but evaluations of its online application to 
mammalian cell cultures are minimal.15,16 
A number of studies have been carried out using multivariate analysis of spectroscopic 
data to develop calibration models capable of simultaneous monitoring of several key 
analytes in a bioreactor.17-20  Emphasis has been placed on the importance of the 
calibration set and Cervera et al. outline various techniques employed for NIR 
spectroscopy.21  There has been much debate on the selection of the optimum 
calibration sample set, with some researchers choosing purely synthetic sample 
matrices arguing that the use of such samples provides accurate results over wide 
concentration ranges and proves a more difficult validation test for the model.22  
Others favour the use of real fermentation samples highlighting fermentation are 
broths impossible to simulate.9,11  The final option is that of a combined sample set, 
one containing spectra obtained from real samples and/or spiked samples and/or 
synthetic samples.  This method has also been used by researchers when developing 
calibration matrices.23,24  The study presented here performs a comparative 
investigation by examining the efficacy of various MIR models for glucose and lactate 
prediction both in-situ and at-line.  Models were created using spectra collected from 
synthetic samples only, a combination of synthetic and real cultures samples (collected 
offline) and finally from all sample types; synthetic samples and real culture samples 
(collected online and offline).   
The purpose of this study was to evaluate the capability of MIR as both an online in-
situ and at-line tool for glucose and lactate monitoring when applied to a mammalian 
cell culture.  This was achieved by application to a series of CHO DP12 cultures in a 
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bioreactor, but also by further analysis of spectroscopic data collated.  A direct 
comparison between models, with various calibration sets and also spectral pre-
treatments is provided in order to identify an optimum methodology for MIR 
calibration model development for the purpose of monitoring media constituents 
within a bioreactor.     
 
4.2  Materials & Methods 
4.2.1  Cell culture 
A series of 3 batch cultures was completed in a bio-reaction calorimeter, RC1e 
(Mettler-Toledo AutoChem Inc., Columbia MD, USA).  CHO DP12 cells were 
cultivated in suspension in 1.6L of media (ExCellTM 325 PF CHO, Sigma Aldrich 
Ireland Ltd.) which was supplemented with Antifoam C, glutamine, insulin & MTX 
(Sigma Aldrich Ireland Ltd.).  Samples were removed every 24 hours and cell counts 
performed manually.  The pH of the culture was controlled and maintained between 
pH 7.0 and pH 7.2 using 2 M NaOH and CO2.  Dissolved oxygen was also monitored 
and entered the reactor via a ring sparger.  The reactor temperature was controlled at 
37 oC for the duration of each of the 3 cultures. 
 
 
Fig. 4.1 Bio-reaction calorimeter, RC1e, with controller set up 
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4.2.2  Instrumentation and real time monitoring 
The cell culture environment within the reactor was monitored in real time using a 
Fourier transform mid-infrared ReactIR iC10 instrument with MCT detector (Mettler 
Toledo AutoChem, Inc., Columbia, US).  A K6 conduit 16 mm immersion probe was 
used with a fixed path length of approx. 1-2 µm and a diamond ATR crystal with 6 
internal reflections.  The detector and probe were purged with nitrogen gas 
continuously.  Prior to media transfer to the reactor, the vessel was filled with 
deionised water and heated to 37 oC.  A background scan was taken at this point.  
Under sterile conditions the water was removed, the media added and the reactor 
inoculated.  The instrument was set to scan every 10 minutes, with each scan 
comprising 128 co-added scans.  All data was collected on the instrument software, iC 
IRTM (Mettler-Toledo AutoChem Inc., Columbia MD, USA).  As the spectral files 
were generated, they were exported to a MATLAB program (v7.9.0.529 (R2009b), 
The MathWorks Inc., Cambridge, UK), where previously developed PLS models25 
developed on the PLS toolbox for MATLAB (V6.2 Eigenvector Research Inc, 
Wenatchee, WA, US) were used to predict the concentration of glucose and lactate 
present inside the bioreactor.  A check was included in the program in an attempt to 
eliminate predicted concentrations that were impossible, i.e. sudden drops or increases 
in concentration which could not reasonably be obtained within the 10 minutes 
between each scan.   
 
4.2.3  Reference analysis  
The first of the 3 cultures ran until day 7, after which time cell counts indicated that the 
culture had moved from stationary to death phase.  The following 2 cultures ran to day 
6.  All cultures were sampled daily.  Once cell counts were completed the samples 
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were prepared for offline analysis.  Raw samples were centrifuged and the supernatant 
retained.  Glucose and lactate concentrations were determined by HPLC analysis.  The 
supernatant was filtered using a 0.22 µm hydrophilic PTFE filter (Millipore 
Corporation, Billerica, MA, USA).  A sample volume of 12 µl was injected onto a 
SUPELCOGEL C-610H column (Sigma-Aldrich Corporation, St. Louis, MO, USA) 
equilibrated with 0.01 M sulphuric acid solution at a flowrate of 0.5 ml/min 
 
4.2.4  Offline/at-line spectra collection and analysis 
The supernatant samples (total of 22) were stored at -80 oC until all 3 cultures were 
complete, after which time they were thawed, heated to 37 oC and scanned offline and 
in triplicate against a background of deionised water at 37 oC.  The calibration models 
used to predict the concentrations of the 2 components of interest in real time (see 
Table 4.1) were then applied to the spectral data generated from the offline scans in 
order to determine if the accuracy was improved when the instrument was not subject 
to the environmental conditions of a cell culture.  This study was performed in order to 
investigate the at-line capabilities of both the instrument and the models.   
 
4.2.5  Model development and optimisation 
The development of the multivariate models applied to the spectral data collected 
during the 3 cell cultures has been fully described in a previous study.25  All models 
created were based on a 7-level partial factorial design.26  Synthetic samples (49) were 
generated to reflect the conditions of a cell culture environment, however actual 
culture samples, were not included in the model development.  Table 4.1 summaries 
the PLS regression models used for in-situ application.  These models, developed in a 
previous study, both use mean centering and 2nd derivative Savitzky-Golay as pre-
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treatments.  Mean centering is often performed as a default pre-treatment.  It was 
selected here as it prevents data points that are further from the origin exerting an 
undue amount of leverage over the points that are closer to the origin.  In this case, as 
the cultures were run over the course of a week, it minimised the effect of instrument 
drift on the model results.  Second derivative Savitzky-Golay or S-G smoothing, as it 
is also known; enhances small spectral differences and separates overlapping peaks.  
As the culture medium contains several components, some of which are unknown, this 
form of pre-treatment was selected to separate merging spectral peaks occurring as a 
result of the many components present in the culture.   
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TABLE 4.1  PLS regression models for in-situ & at-line application  
 
Model # Component Pre-treatment No. Latent 
Variables 
Wavenumber 
Range (cm-1) 
1 Glucose Mean centered 
2nd derivative Savitzky-
Golay, filter width 15 
4 950-1450 
1 Lactate Mean centered 
2nd derivative Savitzky-
Golay, filter width 15 
4 1000-1620 
 
Models used to predict glucose and lactate concentrations were further processed in an 
effort to optimise such models and create more robust and reliable predictions.  The 
calibration sets were expanded to include spectra taken in-situ during the culture, 
and/or culture sample spectra collected offline.  These models are referred to 
throughout this text as “hybrid models” as the x-data required in generating these 
regression models is a composite of spectral data obtained from synthetic and real 
culture samples.   
 
Four model categories are presented, the first of which has been outlined in detail in 
Table 4.1.  PLS regression, optimised by leave-one-out cross validation was used to 
develop all calibration models.  All data was mean centered and second derivative pre-
treatments, of filter widths 15 and 21 were applied, calculated using Savitzky-Golay 
filters.27  Second derivative pre-treatments were chosen as they can eliminate the effect 
of linear baseline off-sets28 that are likely to occur over the course of a culture and 
smooth noisy spectra.  Standard normal variate (SNV) pre-treatment was also applied 
to mean centred data.  This pre-treatment is predominantly used for NIR spectra as it 
removes multiplicative interferences of scatter and particle size29 however it was also 
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examined in this study as a potential pre-treatment due to the nature of the cell culture 
environment (increasing turbidity due to biomass growth). 
 
The second model category was divided into 2 sub-models:  Model 2a and Model 2b, 
as they were largely similar, however the calibration set size of Model 2b was smaller 
and the validation sets used for both models were different.  Model 2a consisted of the 
49 original spectra obtained from scans of the synthetic samples and also spectra 
collected offline from all 3 cultures (22 culture samples) creating a training set of 71 
samples.  Using this data 3 models were developed for both glucose and lactate.  These 
models differed in pre-treatments applied and/or the number of latent variables used.  
Table 4.2 provides specific details for all models developed.  All versions of Model 2a 
were applied to the in-situ data generated during cultures 1, 2 and 3. 
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TABLE 4.2  Hybrid model details 
 
Model Type Component 
Pre-treatments & 
Latent Variables 
Calibration data set Validation data set 
2a Glucose MC_2der15_4LVa 49 synthetic samples, 22 offline spectra (cultures 1,2 &3) In-situ spectra:  Cultures 1,2 & 3 
2a Glucose MC_2der21_5LV 49 synthetic samples, 22 offline spectra (cultures 1,2 &3) In-situ spectra:  Cultures 1,2 & 3 
2a Glucose MC_SNV_5LV 49 synthetic samples, 22 offline spectra (cultures 1,2 &3) In-situ spectra:  Cultures 1,2 & 3 
2a Lactate MC_2der15_4LV 49 synthetic samples, 22 offline spectra (cultures 1,2 &3) In-situ spectra:  Cultures 1,2 & 3 
2a Lactate MC_2der21_3LV 49 synthetic samples, 22 offline spectra (cultures 1,2 &3) In-situ spectra:  Cultures 1,2 & 3 
2a Lactate MC_SNV_4LV 49 synthetic samples, 22 offline spectra (cultures 1,2 &3) In-situ spectra:  Cultures 1,2 & 3 
2b Glucose MC_2der15_4LV 49 synthetic samples, 11 offline spectra (cultures 1,2 &3) 11 offline spectra:  Cultures 1,2 & 3 
2b Glucose MC_2der21_6LV 49 synthetic samples, 11 offline spectra (cultures 1,2&3) 11 offline spectra:  Cultures 1,2 & 3 
2b Glucose MC_SNV_4LV 49 synthetic samples, 11 offline spectra (cultures 1,2&3) 11 offline spectra:  Cultures 1,2 & 3 
2b Lactate MC_2der15_3LV 49 synthetic samples, 11 offline spectra (cultures 1,2&3) 11 offline spectra:  Cultures 1,2 & 3 
2b Lactate MC_2der21_3LV 49 synthetic samples, 11 offline spectra (cultures 1,2&3) 11 offline spectra:  Cultures 1,2 & 3 
2b Lactate MC_SNV_4LV 49 synthetic samples, 11 offline spectra (cultures 1,2&3) 11 offline spectra:  Cultures 1,2 & 3 
 
   
 
 
 
       Chapter 4  
 95 
 
 
Model Type Component 
Pre-treatments & 
Latent Variables 
Calibration data set Validation data set 
3 Glucose MC_2der15_4LV 49 synthetic samples, in-situ spectra (cultures 1&2) In-situ spectra: Culture 3 
3 Glucose MC_2der21_4LV 49 synthetic samples, in-situ spectra (cultures 1&2) In-situ spectra: Culture 3 
3 Glucose MC_SNV_6LV 49 synthetic samples, in-situ spectra (cultures 1&2) In-situ spectra: Culture 3 
3 Lactate MC_2der15_3LV 49 synthetic samples, in-situ spectra (cultures 1&2) In-situ spectra: Culture 3 
3 Lactate MC_2der21_3LV 49 synthetic samples, in-situ spectra (cultures 1&2) In-situ spectra: Culture 3 
3 Lactate MC_SNV_4LV 49 synthetic samples, in-situ spectra (cultures 1&2) In-situ spectra: Culture 3 
4 Glucose MC_2der15_4LV 
49 synthetic samples, in-situ spectra (cultures 1&2), offline 
spectra (cultures 1,2&3) 
In-situ spectra: Culture 3 
4 Glucose MC_2der21_5LV 
49 synthetic samples, in-situ spectra (cultures 1&2), offline 
spectra (cultures 1,2&3) 
In-situ spectra: Culture 3 
4 Glucose MC_SNV_5LV 
49 synthetic samples, in-situ spectra (cultures 1&2), offline 
spectra (cultures 1,2&3) 
In-situ spectra: Culture 3 
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Model Type Component 
Pre-treatments & 
Latent Variables 
Calibration data set Validation data set 
4 Lactate MC_2der15_3LV 
49 synthetic samples, in-situ spectra (cultures 1&2), offline 
spectra (cultures 1,2&3) 
In-situ spectra: Culture 3 
4 Lactate MC_2der21_3LV 
49 synthetic samples, in-situ spectra (cultures 1&2), offline 
spectra (cultures 1,2&3) 
In-situ spectra: Culture 3 
4 Lactate MC_SNV_4LV 
49 synthetic samples, in-situ spectra (cultures 1&2), offline 
spectra (cultures 1,2&3) 
In-situ spectra: Culture 3 
a:  MC = mean centered; 2der15 = Savitzky-Golay 2nd derivative pre-treatment with filter with of 15; 2der21 = Savitzky-Golay 2nd derivative pre-treatment with filter with of 21; LV = latent variables 
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The calibration set used in the development of Model 2b also contained the 49 original 
spectra collected from the synthetic samples, but in this case only 11 of the 22 spectra 
obtained from the offline culture samples were added.  Model 2b was then applied to 
the remaining 11 offline spectra in order to establish if the addition of spectral data 
obtained from an actual cell culture sample enhanced the predictive ability of an at-line 
model.  As with model 2a, 3 PLS regression models were developed for each of the 2 
components of interest.   
 
Model 3 comprised the original 49 spectra and spectra obtained each day, in-situ, at the 
time of sampling, during the first 2 cultures.  This model was then applied to the online 
spectra generated over the course of the third culture.  The training sets for glucose and 
lactate for Model 3 differed slightly.  Based on the in-situ application analysis in this 
study and the limit of detection investigation completed in an earlier study,25 the 
glucose scans were found to be unreliable once the glucose concentration fell below its 
limit of detection. Only spectra collected prior to this point were included in the 
development of the new glucose models.  Therefore only spectra collected at the 
sample time from day 0 to day 3 were used.  Lactate was formed and from day 0 
lactate levels lay above the minimum detection limit, therefore all spectra collected at 
the sample time during the first two cultures were used in the newly developed lactate 
models.  
 
In the final model, Model 4, the 22 spectra collected offline were added to the training 
sets of Model 3, for glucose and lactate.  This model was then applied to the in-situ 
spectral data of the third culture.      
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4.3  Results and Discussion 
4.3.1  In-situ application  
Glucose and lactate concentrations were predicted in real time as all 3 cultures 
progressed.  Reference analysis via HPLC showed that the actual glucose 
concentration in each of the cultures began at 3.0g/L ± 0.2g/L and fell to 0g/L.  The 
glucose versus time plots in Fig. 4.1 show that the online predicted glucose 
concentrations followed this trend in depletion.  This trend has been reported in other 
studies.30-32 However to the authors’ knowledge, only two other studies exist where 
measurements of a mammalian cell culture were taken in real time using an MIR 
immersion probe, and therefore directly comparable.15,16  As the glucose approached 
its limit of detection (LOD) of 0.41g/L, established in a previous study,25 the results 
became unreliable.  In cultures 1 and 3, in-situ results predicted an increase in glucose, 
having reached a minimum of 0g/L, and culture 2 predicted negative concentrations.  
(Note: due to unplanned instrument downtime during culture 2 there are 15 hours on 
day 5 over which in-situ data was not collected).  These spurious spectra, exhibited by 
all 3 cultures may be as a result of increased biomass concentration from day 4, 
causing probe fouling, however, the lactate results did not appear to be impacted by 
possible physical changes in the cell culture environment, and so it is most likely that 
in-situ, predicted glucose values after day 4 were unreliable as the glucose 
concentration in the bioreactor had fallen below a detectable limit.   
 
The root mean squared error of prediction, (RMSEP), was used to evaluate each of the 
models.33  The RMSEP was calculated based on data collected in-situ from all 3 
cultures.  This was found to be 0.73g/L; quite a large error given the maximum value 
of glucose at anytime was 3.0g/L ±0.2g/L.  This value was recalculated using only data 
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generated from day 0 to day 3 of all cultures and was reduced to 0.6g/L, thereby 
improving the error by 17.80%.  An obvious trend in glucose depletion was observed, 
however the level of accuracy required for application to real time monitoring and 
control of mammalian cell cultures was not reached using this set up and method of 
model development.  Therefore further optimisation of the model was investigated. 
 
HPLC results for lactate showed that the minimum starting concentration was 0g/L.  
The lactate concentration reached a maximum on day 4 where concentrations of all 3 
cultures were 2.78g/L ± 0.06g/L with a slight drop in concentration over the remaining 
days of each culture.  The lactate versus time plots in Fig. 4.1 show that the in-situ 
predicted lactate concentrations followed the observed trend, with in-situ 
concentrations peaking on day 4 and then dropping by ~0.35g/L.  However all 3 
cultures indicate that predicted lactate concentrations consistently fell below actual 
lactate values.  The average maximum difference between actual and predicted 
concentrations, over the course of all 3 cultures was 1.65g/L, a considerable difference 
and over 50% of the maximum lactate concentration reached for all 3 cultures.  
However the clear and precise trending exhibited by all 3 cultures suggests that further 
optimisation of the model used may further reduce the deficit and create more robust 
and reliable models.  An RMSEP value of 1.21g/L was calculated for lactate.  Spectral 
data and predicted concentrations did not indicate unreliable, spurious results after day 
4, therefore unlike glucose, a second RMSEP value based on days 0-3 was not 
calculated.  
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Fig. 4.2 (a) 
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Fig. 4.2 (b) 
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Fig. 4.2 (c) 
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Fig. 4.2 (d) 
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Fig. 4.2 (e) 
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Fig. 4.2 (f) 
 
Fig. 4.2 (a-f)  Online, offline & HPLC results of glucose & lactate ‘v’ time for 
cultures 1, 2 & 3 
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4.3.2  At-line application 
Daily samples from all 3 cultures were retained to perform offline/at-line analysis.  
Glucose and lactate concentrations for all 22 samples were predicted using the PLS 
regression models outlined in Table 4.1.  Fig. 4.2 summarises the in-situ, offline and 
HPLC results for glucose and lactate trends for all 3 cultures.  Based on these plots it is 
evident that the offline method is more effective.  RMSEP values were calculated as a 
means of evaluating the comparison between both in-situ and at-line applications.  At-
line prediction yielded a glucose RMSEP value of 0.26g/L, a 60.27% decrease on the 
real time value of 0.73g/L, while the lactate RMSEP fell to 1.02g/L, a 13.22% 
reduction on the in-situ RMSEP of 1.21g/L.  Table 4.3 summarises the comparison of 
both methods. 
 
 
Table 4.3  In-situ versus at-line prediction comparison 
 
Glucose Lactate 
In-situ At-line In-situ At-line 
RMSEP 
(g/L) 
RMSEP 
(g/L) 
RMSEP 
(g/L) 
RMSEP 
(g/L) 
0.73 0.29 1.21 1.05 
 
 
The improvement in the predictive abilities of the instrument may be attributed to a 
number of factors:  the constant flux within the reactor and the possible minor 
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vibrations of the probe due to instrumentation mechanics were eliminated.  All 
samples were scanned in a controlled environment without agitation and impact of 
external physical influences.  A known cause of spurious scans was removed by 
application of this technique; that being the formation of gaseous bubbles on the probe 
tip.  In the aqueous cell culture environment of a bioreactor, real time monitoring using 
an immersion probe is subject to frequent and unpreventable formation of bubbles on 
monitoring devices.34  This is further compounded by the required aeration of the cell 
culture.  Such bubbles, either partially or fully covering the probe tip, skew the results 
as the IR may penetrate into the gas within the bubble thereby producing an inaccurate 
“snapshot” of the contents of the reactor.  The effect of this may be mitigated by 
programming the data acquisition system to reject scans that are not plausible, as was 
done in this case.  At-line analysis allows for the removal of bubbles prior to initiation 
of scanning.   
 
Though not appearing to be problematic in this instance, potential fouling of the probe 
in the latter stages of the cell culture, due to high cell densities is also eliminated.  The 
at-line method removed cellular matter by centrifugation of samples and scanning of 
the resulting supernatant.  
 
4.3.3  Model optimisation 
Spectral data generated both in-situ and offline was used to further develop optimised 
PLS models.  The details of these hybrid models are outlined in Table 4.2.  Second 
derivative pre-treatments consistently resulted in improved predictions; however the 
optimum filter window varied depending on the model type.  The SNV pre-treatment 
did not show the same improved prediction, see Fig. 4.3 and Fig. 4.4, and in the case of 
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glucose, the RMSEP values of hybrid models using SNV pre-treatment failed to 
improve upon the RMSEP values of the original model (Table 4.1).  Hybrid model 
results are outlined in Table 4.4 and Table 4.5.      
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Fig. 4.3 (a)  Model 2a; Culture I 
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Fig. 4.3 (b)  Model 2a; Culture I 
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Fig. 4.3 (c)  Model 2a; Culture II 
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Fig. 4.3 (d)  Model 2a; Culture II 
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Fig. 4.3 (e)  Model 2a; Culture III 
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Fig. 4.3 (f) Model 2a; Culture III 
 
 
Fig. 4.3 (a-f) Hybrid models type “2a” applied to cultures 1, 2 &  
  Chapter 4  
 109 
 
-2
-1
0
1
2
3
4
0 20 40 60 80 100 120 140 160
G
lu
co
se
 c
o
n
c.
 (
g
/L
)
Time (hrs.)
49 syn_mc_2der15_4LV
glucose_3_MC_2der15_4LV
glucose_3_MC_2der21_4LV
glucose_3_MC_SNV_6LV
HPLC 
 
 
Fig. 4.4 (a) Model 3; Culture III 
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Fig. 4.4 (b) Model 3; Culture III 
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Fig. 4.4 (c) Model 4; Culture III 
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Fig. 4.4 (d) Model 4; Culture III 
 
Fig. 4.4 (a-d) Hybrid models type “3 & 4” applied to culture III 
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Table 4.4  Glucose hybrid model results 
 
Model 
 
RMSEP 
(g/L) 
Test set 
 
49 syn_mc_2der15_4LV 
 
0.73 
 
in-situ spectra, cultures 1,2&3 
glucose_2a_MC_2der15_4LV 0.65 in-situ spectra, cultures 1,2&3 
glucose_2a_MC_2der21_5LV 0.77 in-situ spectra, cultures 1,2&3 
glucose_2a_MC_SNV_5LV 1.17 in-situ spectra, cultures 1,2&3 
 
49 syn_mc_2der15_4LV 
 
0.29 
 
off-line spectra, cultures 1,2&3 
glucose_2b_MC_2der15_4LV 0.18 off-line spectra, cultures 1,2&3 
glucose_2b_MC_2der21_6LV 0.21 off-line spectra, cultures 1,2&3 
glucose_2b_MC_SNV_4LV 0.44 off-line spectra, cultures 1,2&3 
 
49 syn_mc_2der15_4LV 
 
0.14 
 
in-situ spectra, culture 3 
glucose_3_MC_2der15_4LV 0.34 in-situ spectra, culture 3 
glucose_3_MC_2der21_4LV 0.72 in-situ spectra, culture 3 
glucose_3_MC_SNV_6LV 0.63 in-situ spectra, culture 3 
 
49 syn_mc_2der15_4LV 
 
0.14 
 
in-situ spectra, culture 3 
glucose_4_MC_2der15_4LV 0.31 in-situ spectra, culture 3 
glucose_4_MC_2der21_5LV 0.39 in-situ spectra, culture 3 
glucose_4_MC_SNV_5LV 0.57 in-situ spectra, culture 3 
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Table 4.5  Lactate hybrid model results 
 
Model 
 
RMSEP 
(g/L) 
Test set 
 
49 syn_mc_2der15_4LV 
 
1.21 
 
in-situ spectra, cultures 1,2&3 
lactate_2a_mc_2der15_4LV 0.46 in-situ spectra, cultures 1,2&3 
lactate_2a_MC_2der21_3LV 1.02 in-situ spectra, cultures 1,2&3 
lactate_2a_MC_SNV_4LV 0.69 in-situ spectra, cultures 1,2&3 
 
49 syn_mc_2der15_4LV 
 
1.05 
 
off-line spectra, cultures 1,2&3 
lactate_2b_MC_2der15_3LV 0.38 off-line spectra, cultures 1,2&3 
lactate_2b_MC_2der21_3LV 0.36 off-line spectra, cultures 1,2&3 
lactate_2b_MC_SNV_4LV 0.93 off-line spectra, cultures 1,2&3 
 
49 syn_mc_2der15_4LV 
 
0.96 
 
in-situ spectra, culture 3 
lactate_3_MC_2der15_3LV 0.49 in-situ spectra, culture 3 
lactate_3_MC_2der21_3LV 0.46 in-situ spectra, culture 3 
lactate_3_MC_SNV_4LV 0.87 in-situ spectra, culture 3 
 
49 syn_mc_2der15_4LV 
 
0.96 
 
in-situ spectra, culture 3 
lactate_4_MC_2der15_3LV 0.96 in-situ spectra, culture 3 
lactate_4_MC_2der21_3LV 0.50 in-situ spectra, culture 3 
lactate_4_MC_SNV_4LV 0.87 in-situ spectra, culture 3 
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The original glucose and lactate models were developed based on the identification of 
8 common cell culture components (glucose, lactate, ammonia, glutamine, glutamate, 
sodium bicarbonate, phosphate and HEPES).  Using these 8 components a cell culture 
environment was simulated and the calibration models developed.  To optimise these 
models the effects of both unknown media components and products produced during 
the cell culture were accounted for in the model development.  Model type 2a (Table 
4.2), which consisted of synthetic samples and culture samples collected offline, was 
applied to the in-situ spectra of all cultures.  Glucose results indicated an improvement 
on the RMSEP of 10.96% while the lactate error fell from 1.21g/L to 0.46g/L, 
resulting in a 61.98% improvement.  Optimum models for predictions of in-situ 
glucose and lactate spectra were hybrid models utilising mean centering and Savitzky-
Golay second derivative (filter width of 15) pre-treatments.  The addition of actual 
culture samples to the calibration sets fortified the models and improved the accuracy 
of the model when applied to spectra collected in-situ in the reactor. 
 
Model type 2b was applied to the offline spectra not included in the calibration set in 
order to determine if the offline/at-line predictions could be improved.  It has already 
been seen that the original models preformed better when applied to offline/at-line 
culture spectra.  Again, hybrid 2b models   performed better than the original models.  
The error of prediction for glucose fell from 0.29g/L to 0.18g/L, a 37.93% 
improvement and for lactate fell from 1.05g/L to 0.36g/L, an improvement of 60.95%.  
In the case of glucose, a narrower filter width of 15 points in the second derivative pre-
treatment performed best, while lactate results favoured a larger filter width of 21 
points.  These results highlight the importance of pre-treatment selection and 
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application and show different components with differing spectra may give better 
predictions with different spectral pre-treatments.  
 
Both model types 2a and 2b indicate that the inclusion of real culture sample spectra, 
which contain unknown components due to the proprietary formulation of many cell 
culture media, create more robust and reliable models for both online and at-line 
purposes. 
 
Model type 3 was developed in order to investigate if the addition of spectra collected 
in-situ could further enhance results.  As with models 2a and 2b, the additional spectra 
used in this calibration set were obtained from actual cell cultures, therefore allowing 
for the effect of unknowns to be built into the model.  However as the spectra used to 
augment the calibration set were collected in-situ, other factors, not accounted for in 
the previous hybrid models were incorporated into the model, such as environmental 
and external influences. 
 
Table 4.4 shows the errors obtained for all models of type 3, for glucose.  None of the 
hybrid models resulted in an improvement on the original model when applied to the 
selected validation set.  Although data collected after glucose had reached its LOD was 
omitted, the trends exhibited in Fig. 4.1 showed that even at an early stage glucose 
spectra collected online were not reliable, and the predictive error associated with the 
online measurements was quite large (0.73g/L).   
 
Therefore the addition of such unreliable spectra to the calibration set only served to 
increase noise in the models and the additional chemical information that improved the 
performance of Model 2a was made ineffective.  
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Fig. 4.1 indicates that although lactate concentrations fell short of the reference values 
consistently, the resulting online trends were reliable.  Smooth, steady trending was 
observed, and the slight decrease in the lactate concentration on day 4 was evident in 
the predictions of in-situ spectra for all 3 cultures.  Addition of in-situ spectra created 
more robust models which, unlike glucose, do not appear to be as affected by the 
environmental factors in the reactor possibly due to the fact that the main absorbance 
peaks for lactate are in a different region to those for glucose.  All model type 3 hybrid 
models performed better than the original model, with the optimum model resulting in 
a 52.08% improvement. 
 
Model type 4 was in essence, an extension of model type 3.  The purpose of this 
model was to investigate if a sheer volume of calibration samples could improve 
already existing models.  The training set used for model type 4 contained spectra 
collected from all possible scenarios – synthetic spectra, online spectra and offline 
spectra, thereby including all possible factors.  Glucose and lactate results for model 4 
exhibited the same trend as for model 3, i.e. glucose results were not improved while 
those for lactate were.  This was as expected as the addition of the in-situ spectra to the 
calibration set had a large influence on the efficacy of the models.  
 
The optimisation of the models highlighted areas where unreliable spectral data was 
obtained, but also where reliable data could be further worked upon to create improved 
and robust models (up to 62% improvement).     
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4.4  Conclusion 
This study evaluated the application of mid-infrared spectroscopy to the upstream 
processing of a CHO DP12 cell line, for the purpose of monitoring glucose and lactate 
concentrations during the cultivation.  Both in-situ and at-line methods were assessed 
using an FTIR immersion probe.  Predictions from a calibration model developed with 
only synthetic mixtures of typical cell culture media components and products of 
metabolism, exhibited the expected trends of glucose consumption and lactate 
production, however the prediction errors were considerable for in-situ application, 
and when glucose fell below its LOD, results became unreliable.  Therefore in-situ, 
real-time application of this system may only be considered practicable where the 
concentration of these components remains above the LOD, such as in a fed-batch 
application or where simple trending of substrates and metabolites is required.   
 
Using the same calibration models as applied in-situ, an at-line study was carried out.  
This application proved more reliable as prediction errors for both glucose and lactate 
fell, indicating that at-line application may be a viable means of monitoring these 
components of interest.  Despite the improvement in results for at-line application, this 
method also poses a number of problems if it is to be incorporated into a PAT system.  
It requires the removal of the sample from the reactor and while it is faster than typical 
laboratory analysis, it still requires a sterile sampling system, one of the major 
advantages of online monitoring.  An at-line monitoring system also cannot be 
integrated into a control system to the same level as an online monitoring system. 
  
An investigation was carried out to determine if the glucose and lactate calibration 
models used for in-situ and at-line analysis could be optimised.  This optimisation 
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study resulted in a number of hybrid models.  In all cases where hybrid models were 
developed using spectra collected offline/at-line, the optimum model was always a 
hybrid model.  This highlights the importance of including spectra collected from 
actual culture samples in the model training set. 
 
When in-situ spectra were used to augment the calibration set, for glucose models, 
predictions did not improve.  This result emphasises an important point, which is that a 
model is only as good as the spectra used to create it i.e. the glucose models containing 
spectra collected in-situ, did not perform as well as those without. The addition of the 
in-situ samples increased noise rather than true chemical information.  In the case of 
lactate, all hybrid models were an improvement on the original model.   
 
In summary, this method can be applied in-situ for monitoring and potentially control 
purposes and accuracy of the predictions can be improved by the addition of actual 
culture samples to the training set and also by varying pre-treatments used.             
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Chapter 5 
Study 3:  The use of Mid-infrared spectroscopy as an on-line PAT tool in total 
and recombinant protein monitoring 
 
Abstract: 
The aim of this study was to establish the feasibility in using mid-infrared (MIR) 
spectroscopy as on online monitoring tool for protein production at various stages in a 
bioprocess.  This exploratory work involved a number of steps to determine firstly, the 
possibility of using MIR for total and recombinant protein detection and secondly, the 
efficacy of this technique for online use.  An initial principal component analysis 
(PCA) was performed using 5 common proteins and the recombinant protein of 
interest.  Results indicated that the MIR immersion probe used was capable of 
distinguishing between the differing proteins, highlighting the potential of MIR as a 
qualitative process analytical technology (PAT) tool for protein detection and 
characterisation.  Using process samples provided by an industrial collaborator several 
partial least squares regression (PLS) models were developed to establish the 
possibility of using this technique as a quantitative PAT tool in online protein 
monitoring.  Models capable of evaluating total and recombinant protein were 
constructed.  Results indicated a greater accuracy in the prediction of the total protein 
with a minimum percentage error of prediction (PEP) of 2.39%.  The smallest PEP for 
the recombinant protein was found to be 6.66%.  These results highlight the existing 
potential for the application of this technique to in-situ protein monitoring.  Due to the 
limited available size of the calibration set, this study also raised questions as to the 
  Chapter 5  
 124 
 
best means of evaluation of results.  This work outlined 2 possible methods for model 
evaluation; standard error of cross validation and standard error of prediction.  Each 
technique was examined and results based on these methods were presented for 
comparative purposes.  Finally, an investigation into the impact of 2 detergents on 
model performance was completed.  As detergents are frequently used in the course of 
the bioprocess for e.g. protein solubilisation or virus inactivation, a PCA was 
completed to determine if the presence of detergent would be likely to affect protein 
predictions.  This analysis indicated that detergents were likely to impact results, 
particularly at concentrations at the higher end of the typically used range.  
 
5.1  Introduction   
Traditional protein quantification techniques such as SDS-Page are laborious, 
requiring considerable sample preparation and processing time.  Due to the amount of 
interaction with the process sample, these methods are also open to error at any one of 
the many analysis steps.  Current, conventional methods also require the removal of a 
sample from the bioreactor and result in sample destruction.  Mid-infrared 
spectroscopy offers an alternative to protein quantification.   
 
MIR is a well established technique in the determination of protein structure.1-3 The 
amide I band located at 1700 – 1600 cm-1 provides a significant amount of 
information.4,5  The C=O stretch at the amide I band is affected by the strength of the 
hydrogen bonds between the C=O bond and the N-H group.2  The resulting variation in 
the absorption of proteins in this region has been utilised to determine secondary 
protein structures.5  Gross-Selbeck et al have further shown that the intensity of the 
absorption at the amide I band corresponds to the quantity of protein in the sample.6  
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Based on this knowledge, MIR has huge potential in protein analysis presenting a 
serious case for its application as a process analytical technology tool (PAT).  
 
Infrared spectroscopy is a powerful tool in bioprocess monitoring.7-9  It is capable of 
simultaneously monitoring several of the components present in a cell culture medium.  
Both near infrared (NIR) and MIR have been used for analyte and metabolite 
monitoring,10-15 with NIR also being applied to cultures as a biomass monitor.16  
Previous studies in the use of MIR in protein detection and classification have focused 
on this technique as a rapid off-line method,2,17,18 with few examining its in-situ 
capabilities.19 
 
Infrared spectroscopy can be used in-situ. In such applications it is non-invasive and 
eliminates the need for sample removal.  In bioprocessing, where sterility is of the 
utmost importance, obtaining samples without compromising the sterility of the system 
is always a major concern.  Non-invasive methods, like in-situ MIR, reduce the risk of 
culture contamination.20  In addition, sample preparation is not required and data is 
obtained instantaneously.  These features meet much of the criteria used to define a 
Process Analytical Technology (PAT) tool, as outlined by the FDA in their “PAT 
Guidance for Industry” framework.21     
 
The purpose of this study was to examine any existing potential for protein detection 
using an in-situ MIR instrument.  The investigative work completed used in-process 
industrial samples to develop PCA and PLS models to examine the feasibility of using 
online MIR, to both qualify and quantify total and recombinant protein.  This study is a 
precursor to further work on model development and optimisation.  It does not present 
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a detailed evaluation of optimum chemometric models but rather establishes a 
methodology for preliminary, exploratory work in determining the efficacy of online 
MIR as a PAT tool for protein detection and monitoring.  In addition, the detergent 
study highlighted the possible difficulties the technique may encounter during the 
processing of recombinant protein.  The impact of 2 commonly used detergents on 
spectral data was investigated to identify any potential influences on the PLS model 
predictions.   Finally, results were evaluated using both root mean square error of 
cross-validation (RMSECV) and root mean square error of prediction (RMSEP) in an 
attempt to answer questions as to the best evaluation method given the size of the 
training and validation sets.22  
 
To the author’s knowledge, no other study exits in which recombinant and total protein 
have been quantified in industrial samples using an MIR immersion probe capable of 
online monitoring.       
 
5.2  Materials & Methods 
5.2.1  Preliminary analysis 
Five commonly used proteins, bovine serum albumin (BSA), human serum albumin 
(HSA), amylase, pepsin and lipase, (Sigma Aldrich, Ireland, Ltd.) in addition to the 
recombinant protein of interest, were selected, on which to perform a preliminary 
analysis.  Standard solutions of each protein, at concentrations of 10, 5 and 2.5 g/L, 
were made.  These solutions were then scanned in triplicate using a Fourier transform 
mid-infrared ReactIR iC10 instrument with MCT detector (Mettler Toledo AutoChem, 
Inc., Columbia, US) against a background of deionised water.  A K6 conduit 16mm 
immersion probe was used with a fixed path length of approx. 1-2 µm and a diamond 
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ATR crystal with 6 internal reflections.  The detector and probe were purged with 
nitrogen gas continuously.  The mean spectrum of each triplicate scan was calculated 
and imported into MatLab (v7.9.0.529 (R2009b), The MathWorks Inc., Cambridge, 
UK).  A scan of each protein at 10 g/L was taken and spectra were plotted for 
preliminary examination.  This allowed for spectral similarities and differences to be 
identified while also establishing the usable wavenumber range for further work.  The 
PLS toolbox for MatLab (V6.2 Eigenvector Research Inc, Wenatchee, WA, US) was 
used to complete a principle component analysis (PCA) to determine if it was possible 
to distinguish between the six different proteins.  Pre-treatments employed for PCA 
investigation were mean centering combined with normalisation and mean centering 
combined with standard normal variate (SNV).  Both these pre-treatments are effective 
at scaling and normalising spectra.   
 
5.2.2  Samples and reference analysis 
Recovery process samples were obtained from an industrial collaborator.  These 
samples contained the recombinant protein of interest, in addition to a large number of 
unknown host cell proteins.  Also present in these untreated samples were cell 
particulates, as samples were previously lysed with acid, and sodium hydroxide, used 
for pH adjustment.  Using these samples, 3 sample types were generated:  untreated 
samples, consisting of the samples in their original form; supernatant samples, 
resulting from untreated sample centrifugation and containing aqueous based 
fermentation broth, sodium hydroxide, proteins and other components soluble in water; 
re-dissolved pellet samples generated by dissolution of the remaining pellet in a Tris 
(Sigma Aldrich, Ireland, Ltd.)/EDTA (VWR International, West Chester, Pennsylvania 
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(USA)) extraction buffer and containing, proteins which were not previously dissolved 
and insoluble cell particulates. 
 
An estimation of the concentration of NaOH present in the untreated and supernatant 
samples was calculated from process data available (as samples were supplied by an 
industrial partner the exact composition of other components was not provided and 
was calculated based on limited data released by the company) and both samples types 
were scanned in triplicate against a background of deionised water and NaOH, at this 
concentration.  The re-dissolved pellet samples were scanned against a background of 
the Tris/EDTA extraction buffer used to dissolve the pellet.  All samples were 
vortexed prior to scanning to ensure homogeneity.       
 
For reference analysis a Bradford assay (Sigma Aldrich Ireland Ltd.) was used to 
quantify the total protein present in the samples.  Assays were performed on all the 
supernatant and re-dissolved pellet samples and the total protein within the untreated 
samples was quantified by summing the results of these.  The recombinant protein was 
determined via SDS-PAGE using precast gels, NuPAGE Novex Bis-Tris Gel 4-12% 
(Invitrogen, Carlsbad, CA, USA).  Again, supernatant and re-dissolved pellet samples 
were used to quantify the recombinant protein present in the untreated samples.    
 
5.2.3  Quantitative model development     
Partial least squares regression (PLS) models were developed to quantify both the total 
protein and the recombinant protein present in the samples.  Untreated in-process 
samples were available from 12 batches and from these 12 samples, the 3 samples 
types were generated as described above.  Samples from 3 of these batches were 
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randomly selected for model validation and the samples from the 9 remaining batches 
were used as the calibration set for the various models.  Four model types were 
generated:  the first model type was developed using all forms of samples, i.e. 
untreated, supernatant and re-dissolved pellet samples; the second, untreated samples 
only; the third, supernatant samples only and the final model type was developed using 
re-dissolved pellet samples only.  Model type 1 therefore had 27 samples for 
development and 9 for validation.  The remaining 3 model types were created using 9 
samples and validated with 3 samples.  Figure 5.1 outlines the experimental design 
employed for total protein model development.  Recombinant protein model 
development followed the same procedure however derivative order, filter width and 
number of latent variables differed.     
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.1 Schematic of experimental design for total protein model development 
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Following the preliminary analysis the usable region of the spectrum was identified to 
be 1700-900cm-1.  Only spectral data lying within this region was selected for model 
development.  All other extraneous data was removed.  This ensured that all models 
were developed based on absorbance data relevant to the protein absorbance area of 
the spectrum and eliminated all other regions which exhibited considerable spectral 
noise and would negatively impact the models.  All spectra were mean centred.  First 
and second derivative pre-treatments, of filter widths 7, 15 and 21 were then applied, 
calculated using Savitzky-Golay filters.23  These pre-treatments were selected as they 
can eliminate the effect of linear baseline off-sets and smooth noisy spectra.24  Results 
tables indicate whether first or second order derivatives were used, in addition to 
specifying the filter width.  These are denoted by XderY, where X is the Savitzky-
Golay Xth derivative pre-treatment and Y, the filter width.  For each of the 4 model 
types, 3 models were developed for both the total protein and recombinant protein 
predictions.  These models varied in the number of latent variables (LV) used and the 
order of the derivative and filter widths of the Savitzky-Golay pre-treatment.   
 
Model efficacy was evaluated in two ways.  The root mean squared error of prediction, 
(RMSEP), was used to assess the models prediction ability using 3 sample batches not 
used in the development of the models.25  Percentage error of prediction (PEP) values 
were calculated in order to put the RMSEP values in perspective.  The PEP was 
calculated by dividing the RMSEP by the average total or recombinant protein 
concentration in the 3 test samples.  Using a calibration or training set to develop a 
model, followed by the use of a completely independent validation set to test the 
model is a procedure typically used and widely applied in the field of chemometrics.  
However this methodology comes with a caveat that should be duly noted, that is, the 
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impact of the size of the calibration and validation sets on the overall model results.  
Where possible, calibration sets should  be large enough to contain all possible forms 
of variation within the samples to ensure the model accounts for all scenarios, both 
expected and unexpected.  The validation set should be capable of unearthing any 
model weaknesses, and should prove a difficult test of the model.  Due to limitations in 
sample availability this is not always feasible.  Kramer acknowledges this and suggests 
that in such circumstances other tests, such as cross validation, be employed as a 
means of evaluating model accuracy.22  As this study was limited by the number of 
samples available for training and validation set compilation, all results were also 
evaluated based on the root mean squared error of cross-validation (RMSECV) and for 
model types 2, 3 and 4, where it was possible to associate a percentage value, the 
percentage error of cross validation (PECV) was also calculated.  ‘Leave-one-out’ 
cross validation was the selected cross validation technique and was used in the 
development of all models generated.  This method is widely used where small sample 
sets are in use.  This procedure removed one sample from the calibration set, 
developed a PLS model from the remaining samples, and then applied this model to 
the removed sample to predict the concentration.  Each sample in turn was removed 
and its concentration predicted.  A prediction error for each of the samples was 
calculated and the RMSECV was determined by combining these errors to generate a 
standard error.   
 
5.2.4  Detergent investigation 
A further, exploratory study was carried out to investigate the impact of the addition of 
2 standard, industrially used detergents, detergent A and detergent B, on untreated 
  Chapter 5  
 132 
 
samples.  As detergent is likely to be introduced at the raw, untreated stage, it was to 
the untreated samples that detergent was added.   
The following samples were scanned and spectra plotted for preliminary examination: 
• Detergent A 
• Detergent B 
• Untreated sample, prior to the addition of any detergent 
• Untreated sample with 3% detergent A 
• Untreated sample with 3% detergent B 
The area of interest was again localised to 1,700 cm-1 – 900 cm-1.   
To 3 aliquots of an untreated sample, concentrations of 0.006%, 1.5% and 3% of 
detergent A were added respectively.  Similarly, concentrations of 0.3%, 1.5% and 3% 
of detergent B were added to another 3 aliquots of the same untreated sample.  The 
selected concentrations were based on recommended range of use for each of the 
detergents.26  All 6 samples were scanned in triplicate and the mean of each spectrum 
obtained.  A qualitative analysis was carried out by performing a PCA.  In addition to 
these 6 spectra collected, 2 spectra, one of each detergent, and six spectra, of untreated 
samples without any detergent present, were added to the data set.  Pre-treatments used 
in advance of the PCA were mean centering with SNV and mean centering with 
normalisation. 
 
5.3  Results and discussion 
5.3.1  Preliminary analysis 
The MIR region is considered to lie between 4000-400 cm-1.  The ATR crystal of the 
probe used in this study absorbs over the range 2250-1950 cm-1, therefore creating an 
instrument ‘blind spot’.  At regions of the spectrum above 2250 cm-1 and below 900 
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cm-1 spectra exhibited considerable noise and were deemed unusable.  Spectra 
immediately adjacent to the lower end of the ‘blind spot’ were also noisy.  This 
effectively reduced the usable wavenumber range to 1700-900 cm-1.  Figure 5.2 shows 
the absorbance, of all 6 proteins investigated, over this region.   
 
 
 
 
 
 
 
 
 
 
Fig. 5.2  Usable MIR spectral region for protein absorbance 
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as the amide modes.3  In the case of the reduced MIR spectral region used here, 
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~1550 cm-1 respectively.  Six overlapping peaks, representing each of the 6 proteins, 
were evident at these locations on the spectrum, highlighting the difficulties 
encountered when attempting to characterise proteins using MIR.  Although each 
protein was present at the same concentration, the intensity of the vibration varied.  
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however these peaks did not entirely overlap at the same point.  Pepsin and the 
recombinant protein reached a maximum at 1076 cm-1, amylase at 1053 cm-1 and 
lipase at 1080 cm-1, while BSA and HSA did not exhibit any peaks at all.  This 
observation supported the notion that it was possible to adequately distinguish between 
all six proteins and a PCA was carried out to determine this.  Figure 5.3 shows the 
optimum PCA, where separation of differing proteins, and clustering of the same 
protein, but varying concentrations, occurred.   
 
 
 
 
 
 
 
 
 
 
Fig. 5.3  Scores plot of 5 common proteins and the recombinant protein of interest 
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of MIR to distinguish between differing proteins, supporting the development of PLS 
calibration models for total and recombinant protein quantification.    
 
5.3.2  Quantitative model development     
For each model developed for model type 1, the RMSECV values for untreated, 
supernatant and re-dissolved pellet samples were the same.  This is because the 
RMSECV is based on the cross validation model error and not a predictive error.  
Therefore it was the same 3 models that were developed and applied to all 3 sample 
types.  Also, it was not possible to calculate a PECV for model type 1 as the actual 
differences in the concentration ranges of all 3 sample types were not comparable and 
so would not provide rational PECV results.  In the case of predictive errors, PEP was 
calculated.  Here a validation set containing all 3 sample types was used and the 
models applied.  Each prediction was therefore associated with a sample type and 
hence a specific RMSEP for each sample type could be calculated and in addition, a 
PEP.  This procedure was applied to both total and recombinant protein evaluations. 
 
Models 2, 3 and 4 were each developed for a specific sample type and as such should 
have a greater degree of accuracy than model type 1 when applied to their associated 
sample types.  This is evident by comparison between Table 5.1 and Table 5.2, which 
outline the total protein cross validation and prediction errors.  Lowest predictive 
errors for model type 1 of the untreated and supernatant models were 10.4% and 
40.23% respectively which remained above the highest predictive errors for the 
specific untreated (model type 2) and supernatant (model type 3) models of 6.97% and 
8.7%.  This trend was also observed for RMSECV values where the lowest RMSECV 
for model type 1 of 3.2961 g/L was greater than the highest RMSECV values for 
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model types 2 and 3, of 2.7282 g/L and 1.1091 g/L respectively.  A direct comparison 
between re-dissolved pellet RMSECV and RMSEP values shows that model type 4, 
which was specific to the re-dissolved pellet samples, did not always perform better 
than model type 1, however the lowest RMSECV and RMSEP values in all cases 
resulted from models generated from specific sample types i.e. model types 2, 3 and 4. 
 
TABLE 5.1  Total protein errors for Model Type 1 
 
Sample Type Model 
RMSECV 
(g/L) 
RMSEP 
(g/L) 
PEP 
(%) 
1der15_12LV 3.2961 2.8855 18.80 
2der15_4LV 4.3027 2.0649 13.46 Untreated 
2der15_12LV 4.6434 1.5955 10.40 
1der15_12LV 3.2961 1.1224 46.31 
2der15_4LV 4.3027 0.9751 40.23 Supernatant 
2der15_12LV 4.6434 1.3059 53.89 
1der15_12LV 3.2961 0.6368 5.29 
2der15_4LV 4.3027 1.6662 13.85 
Re-dissolved 
Pellet 
2der15_12LV 4.6434 0.4591 3.81 
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TABLE 5.2  Total protein errors for Model Types 2, 3 & 4 
 
Model 
Type 
Sample Type Model 
RMSECV 
(g/L) 
PECV 
(%) 
RMSEP 
(g/L) 
PEP 
(%) 
1der15_6LV 2.0902 13.81 1.0701 6.97 
1der15_4LV 2.0922 13.83 1.0391 6.77 
Model 
Type 2 
Untreated 
2der15_4LV 2.7282 18.03 0.7633 4.97 
1der15_6LV 1.1091 35.96 0.1127 3.69 
2der15_2LV 0.5747 18.63 0.2213 7.24 
Model 
Type 3 
Supernatant 
2der15_6LV 0.7507 24.34 0.2651 8.67 
1der15_6LV 2.9132 25.56 0.2795 2.39 
2der15_6LV 3.8104 33.44 0.4757 4.07 
Model 
Type 4 
Re-dissolved 
Pellet 
2der7_7LV 4.0431 35.48 0.6915 5.91 
 
 
 
Direct comparison of Table 5.1 and Table 5.2 shows that despite the evaluation 
method applied; RMSECV or RMSEP, model type 1 did not attain the same level of 
accuracy as model types 2, 3 and 4.  Therefore, although the training sets for model 
types 2, 3 and 4 were one third the size of that used for model type one, the specificity 
of the samples used created more accurate models.  However this does not infer that 
increased accuracy results in more robust models, and it is imperative that variation be 
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built into all models to protect against the occurrence of outliers which could cause the 
model to fail.22  Although not possible in this feasibility study due to limitations in 
sample availability, the training set should be large enough to represent all components 
present at a number of concentration levels, ranging from the minimum to the 
maximum concentrations likely to be encountered, if the calibration is to be applied to, 
and trusted in, the monitoring of a bioprocess.    
 
Recombinant protein errors, shown in Table 5.3 and Table 5.4, followed a similar 
trend to those of the total protein, in that the highest errors for the specific model types 
(model types 2, 3 and 4) were all considerably lower than the lowest errors of the 
general model type 1.  This was true of both the RMSECV and RESEP values and in 
this instance, there were no exceptions. 
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TABLE 5.3  Recombinant Protein errors for Model Type 1 
Sample Type Model 
RMSECV 
(g/L) 
RMSEP 
(g/L) 
PEP 
(%) 
1der15_7LV 0.1975 0.1035 17.30 
2der15_4LV 0.2796 0.1167 19.50 Untreated 
2der7_7LV 0.2400 0.1724 28.80 
1der15_7LV 0.1975 0.1943 68.60 
2der15_4LV 0.2796 0.1809 63.89 Supernatant 
2der7_7LV 0.2400 0.1098 38.77 
1der15_7LV 0.1975 0.0905 26.23 
2der15_4LV 0.2796 0.0979 28.38 
Re-dissolved 
Pellet 
2der7_7LV 0.2400 0.0551 15.98 
 
  Chapter 5  
 140 
 
TABLE 5.4  Recombinant Protein errors for Model Types 2, 3 & 4 
Model 
Type 
Sample Type Model 
RESECV 
(g/L) 
PECV 
(%) 
RMSEP 
(g/L) 
PEP 
(%) 
1der15_4LV 0.0967 14.96 0.0754 12.59 
2der15_4LV 0.0890 13.76 0.0848 14.17 
Model 
Type 2 
Untreated 
2der7_4LV 0.1210 18.72 0.0908 15.18 
1der15_4LV 0.1205 42.41 0.0330 11.66 
2der15_5LV 0.0874 30.75 0.0189 6.66 
Model 
Type 3 
Supernatant 
2der21_4LV 0.1082 38.09 0.0253 8.94 
1der15_7LV 0.0898 23.43 0.0519 15.06 
1der15_3LV 0.0673 17.57 0.0489 14.19 
Model 
Type 4 
Re-dissolved 
Pellet 
2der15_7LV 0.0586 15.29 0.0424 12.30 
 
Considering both the total and recombinant protein predictive errors for model types 2, 
3 and 4, in Table 5.2 and Table 5.4, it was the untreated model type 2 that resulted in 
the greatest errors in both cases.  This was expected as the untreated samples contained 
a large degree of particulates, including un-dissolved proteins, thus making the 
measurement of these samples and accuracy of the model predictions, more difficult 
and unreliable.  However it should be noted that the cross-validation errors did not 
follow this trend.   
 
Cross-validation errors of total and recombinant protein were comparable and results 
did not favour greater accuracy in the prediction of total protein over recombinant 
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protein, or vice versa.  Untreated and supernatant prediction errors however, were 
greater for recombinant protein than those of total protein by a factor of 2, and re-
dissolved pellet errors increased by a factor of 6 for recombinant protein.  The 
concentration of recombinant protein present in each sample was an order of 
magnitude lower than the total protein concentration and therefore more difficult to 
accurately detect.  Also, off-line results for recombinant protein, quantified via SDS-
Page analysis, exhibited a higher variance (6.1-11.3%) than those for total protein 
(3.8%) quantified via Bradford assay.  Increased variance present in the y-data of the 
training set most likely further impacted the accuracy of the recombinant protein 
models.       
 
The trends exhibited by the predictive errors were typical given the constitution of 
each sample type and the concentration of total and recombinant proteins present in the 
samples.  These trends were not exhibited in the RMSECV values however and this 
discrepancy highlights the issues encountered when choosing the optimum technique 
to evaluate all models.  Correct selection involves striking a balance between 
independent validation samples and sufficiently large sample number so as not to 
excessively skew results. 
 
5.3.3 Techniques for model evaluation 
The lowest RMSECV and lowest RMSEP for all model types did not always result 
from the same model i.e. the optimum model for each model type varied depending on 
the method of evaluation.  This result again highlighted the importance in accurately 
assessing the predictive capabilities of the model.  Ideally a validation set used to test a 
model should have as many samples, if not more samples, than the training set used to 
  Chapter 5  
 142 
 
create it.22  However this is seldom the case and an astute assessment of the given 
scenario is necessary.  This study outlined two possible ways of evaluating the 
predictive ability of a model.  As previously mentioned, the preferred technique is the 
application of an independent validation set to test the models accuracy and 
robustness.  This is considered a more rigorous test of the models capabilities and 
results in the calculation of an RMSEP value.  However, where calibration and 
validation sets are limited in sample number this is not necessarily the best method.  In 
such sample sets, one sample can exert undue weight, either favourably or not, leading 
to a conclusion on the predictive capacity of a model that is not wholly accurate.  The 
second method used to evaluate the models capabilities was examining the RMSECV.  
This test is considered to be less demanding on the model as each of the samples used 
to cross validate the model were used in the development of the model and so this 
technique is not entirely independent. 
 
5.3.4  Detergent investigation 
Figure 5.4 outlines the wavenumbers at which detergents A and B and also the 
untreated sample absorbed.  Both detergents exhibited clear and distinct peaks.  It was 
not possible to identify the spectrum of the untreated sample as spectra of samples 
containing untreated sample and detergent masked its presence.  These initial 
observations indicated that models used for the prediction of protein from untreated 
culture broth were likely to be impacted by the addition of detergent to the culture.  
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Fig. 5.4  Spectra of untreated samples, detergents A & B and untreated samples 
spiked with detergents A & B 
 
The scores plot shown in figure 5.5 was generated by performing a PCA using mean 
centering and SNV as data pre-treatment methods.  The PCA indicated that both 
detergents A and B in their pure form, were clearly distinguishable from untreated 
samples.  Samples containing 3 differing concentrations of detergent A separated from 
samples which were not spiked with any detergent, however only the sample with the 
highest concentration of detergent B separated from non-spiked samples, with the 
lower 2 concentrations clustering with these samples.     
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Fig. 5.5  Scores plot of untreated samples; detergents A & B; untreated samples 
spiked with detergents A & B 
 
This preliminary investigation highlighted the potential impact the addition of 
detergent may have on the quantitative protein prediction models.  Separate models 
should be developed for protein prediction depending on whether detergent is present 
or not.  Where detergent is present, the range of its concentration should be 
incorporated into the model to include sample variation.  The protein concentration 
range of each model should also be considered.   Reference samples analysed showed 
that after the addition of detergent A, the concentration of the protein remained the 
same as before. Addition of detergent B to the untreated samples resulted in 
solubilisation of the protein and an increase of up to 4 times the original protein 
concentration in the supernatant samples.  Therefore models constructed for use in the 
presence of detergents that facilitate solubilisation should include a higher upper limit 
concentration to account for increased quantities of soluble protein in the sample.    
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5.4  Conclusion 
This exploratory study indicated that it was possible to qualitatively and quantitatively 
measure total and recombinant protein present in in-process recovery samples using an 
in-situ MIR immersion probe.  This study highlighted the potential of MIR as an 
online monitoring technique for the production of a recombinant protein in a 
bioprocess.    
 
A preliminary PCA indicated that despite the clear overlapping peaks at particular 
wavenumbers, it was possible to distinguish between the 6 proteins selected for this 
study.  It has previously been reported that MIR can be used in the characterisation of 
protein structures however little work has been undertaken in this area using in-situ 
MIR immersion probes.  The specificity of the instrument and its application in a 
particular environment have been shown to have a large bearing on whether or not a 
technique may be deemed acceptable.  Initial analysis in this study indicated MIR has 
potential as a qualitative analysis tool; when applied to protein solutions the technique 
was capable of distinguishing between varying clusters of proteins. 
 
Four model types were identified based on the samples available.  PLS models were 
used to predict the total and recombinant protein present in 9 validation samples in the 
case of model type 1 and 3 validation samples for model types 2, 3 and 4.  Model type 
1 was the least accurate for both total and recombinant protein prediction with highest 
predictive errors in the supernatant samples at 53.89% and 68.60% respectively.  The 
calibration set used for model type 1 was a combined set consisting of all sample 
types.  Although it is recommended that variation be introduced into all models to 
account for atypical scenarios, the samples used to generate model type 1 differed 
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considerably and failed to enhance the robustness of the models.  Results for specific 
models 2, 3 and 4 were consistently more accurate for both total and recombinant 
protein prediction.  Given the limited number of available samples it was not possible 
to develop a thorough model capable of precise predictions while being easily able to 
identify outliers.  Kramer’s “rule of 3” was employed here,22 which he states should 
only be used when completing “preliminary or exploratory work”.  However the 
methodology applied did provide a proof of concept, highlighting the potential of an 
MIR immersion probe in online protein monitoring. 
 
Due to the limited calibration set number, this study also resulted in a comparison of 
model evaluation techniques.  The cross-validation and prediction errors were 
calculated, with cross-validation errors indicating a higher degree of model inaccuracy.  
However, major trends outlined by one method were also reflected in the other; in the 
case of total and recombinant protein prediction, both cross-validation and application 
of an independent validation set indicated that models predicting total protein were 
more accurate, and when comparing the accuracy of model type 1 compared to that of 
the specific models, both techniques favoured the specific sample type models despite 
the lower sample number used in the calibration set.   
 
The detergent investigation study provided insight into the necessary requirements for 
further model development, when detergent is present in the process.  Results for both 
detergents tested indicated that at typically used concentrations, the protein predictions 
would be impacted by their presence and so conclude that further model development 
should account for detergent used in the process.   
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Chapter 6:  Conclusions and Recommendations 
This thesis investigated the use of Fourier Transform Infrared (FT-IR) spectroscopy, in 
the form of an in-situ MIR ATR probe, to determine the potential of this method as a 
PAT tool.  The 3 studies presented provided a detailed account of the capabilities of 
the technique, outlining both the strengths and limitations of this application.  The 
entire work evaluated the use of this technique at varying process steps.  This was 
achieved in 3 studies, which examined its applicability and performance in upstream 
cell cultivation and also, downstream primary recovery.  Initial studies focused on the 
use of in-situ MIR for monitoring of analytes and metabolites present in the 
bioprocess, while the latter study investigated the possibility of using the technique for 
protein quantification.  Results indicated that MIR is deserving of its place in the PAT 
tool kit.  Its capabilities lie both in qualitative and quantitative analysis.  
 
6.1  Study 1:  Potential of Mid-infrared spectroscopy for on-line monitoring of 
mammalian cell culture medium components 
This initial study developed a methodology for evaluating the potential of MIR, for 
monitoring cell cultures medium components.  The comparative probe investigation 
allowed for the identification of the optimum sampling accessory for this given 
application, which was then used in further studies.  The fixed conduit immersion 
probe was found to be more reliable, with fibre-optic probe issues owing 
predominately to the ‘sample to crystal’ interface area.  The design of the interface 
area resulted in frequent bubble entrapment, which consequently impacted results.   
The spectral characterisation study completed identified the main areas of absorbance 
for each of the 8 components under investigation, and provided an indication of the 
areas of interest on the spectrum.  The limit of detection (LOD) analysis highlighted at 
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an early stage, components that were not likely to be detected when the instrument was 
applied in-situ in a bioreactor.  The concentrations of some components, e.g. glutamine 
and glutamate, in a cell culture medium, fell below the LOD.  At this point therefore, 
the preliminary analysis facilitated the identification of components likely to be 
detected on-line and those that were not likely to be detected.  Also, the LOD for a 
given component in a multicomponent mixture was found to be significantly higher 
that of the same component in a single component solution.  It can be concluded that 
the multivariate LOD analysis presented in this study outlines a novel methodology for 
initial evaluation of the technique for a given purpose.   
 
The calibration models developed in this study indicated the applicability of the 
technique in monitoring certain components such as glucose, ammonia and lactate, 
while also highlighting the limitations encountered when the technique is applied to 
media components that are at much lower concentration levels.  It should be noted that 
the accuracy of the prediction ability of a model is very much dependent on the sample 
set size and the concentration level of each of the components present.  This was 
further investigated in study 2.     
 
Finally, the external influence investigation performed provided a novel method for 
pre-empting possible interferences the instrument, and hence the models, would 
encounter when applied on-line.  This allows for understanding and mitigation of 
possible influences, but cannot completely eliminate these prior to on-line application.    
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6.2  Study 2:  Application and optimisation of in-situ MIR calibration models for 
the prediction of glucose and lactate in mammalian cell cultures 
This second study evaluated the application of MIR spectroscopy to the upstream 
processing of a CHO DP12 cell line, for the purpose of monitoring glucose and lactate 
concentrations during the cultivation.  The fixed conduit FTIR immersion probe 
identified in study 1, as the optimum probe for bioprocess monitoring was selected and 
calibration models for glucose and lactate, developed using synthetic samples, were 
applied on-line and at-line.  Both on-line and at-line trends reflected the expected 
trends, and those of the reference analysis, that being the depletion of glucose and the 
increase in lactate.  However, as observed in study 1, when concentration values fell 
below the LOD, results became unreliable.  This was evident in the glucose results of 
all 3 cultures, from day 4, when the glucose concentration fell below the LOD.  
Therefore application of this system may only be considered practicable where the 
concentration of these components remains above the LOD.  Despite the observed 
trending, the prediction errors were considerably large for the in-situ application.  At-
line detection proved more accurate, and presented a viable alternative to on-line 
detection, however, at-line detection is not without its complications and further 
optimisation of the models was investigated.   
 
The optimisation study resulted in the development of a number of hybrid models.  
These models were generated using training sets of spectroscopic data collected from 
synthetic samples, at-line samples and on-line samples.  Where at-line spectroscopic 
data was used in the calibration set, models consistently performed better.  It can 
therefore be concluded that although synthetic samples simulate the composition of the 
culture medium, the addition of spectra collected from “real” culture samples fortifies 
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the models as it accounts for minor unknowns that could impact the spectra, but are not 
accounted for in synthetic samples. 
 
The addition of spectra collected in-situ to the calibration set provided interesting 
results.  In the case of glucose, predictions did not improve.  As previously stated, in-
situ glucose results were not entirely reliable.  When these spectra were used to 
increase the calibration set, they only served to enhance noise and inaccuracies, and 
did not increase the robustness of the models.  This is an important result.  It highlights 
that it is not the quantity of the spectra in a calibration set that will always strengthen 
the model, but also the quality of the spectra.  Should spectra of an inferior quality be 
used in the creation of a model, the accuracy of the model may be compromised.  In 
the case of lactate, all hybrid models were an improvement on the original model, 
however unlike glucose, lactate did not exhibit erratic predictions.   
 
From this study it can be concluded that this technique can be applied in-situ for 
monitoring and potentially control purposes.  Accuracy of calibration models can be 
improved by addition of spectra of actual culture samples; however it is imperative 
that care is taken when choosing spectra to ensure they are of good and reliable 
quality.   
 
6.3  Study 3:  The use of Mid-infrared spectroscopy as an on-line PAT tool in total 
and recombinant protein monitoring 
This final study investigated the potential of MIR spectroscopy in detecting and 
quantifying total and recombinant protein during primary recovery.  A spectral 
characterisation of 5 standard proteins and the recombinant protein of interest was 
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initially performed.  This allowed the region of interest to be identified and clearly 
highlighted the amide I and amide II bands, located at ~1650 cm-1 and ~1550 cm-1 
respectively, which are of great significance when MIR is used for protein 
characterisation.  A PCA was performed on varying concentrations of the 6 proteins.  
This showed that the instrument in question was capable of distinguishing between 
differing proteins, and as a preliminary step, supported the development of PLS 
models suggesting potential for quantifying the recombinant protein of interest.     
 
Using in-process samples, 3 sample types were available; untreated, supernatant and 
re-dissolved pellet samples.  Based on these, four model types were identified; the 
first, using a training set consisting of spectra from all 3 sample types, while each of 
the remaining 3 models types used training sets corresponding to one of the 3 sample 
types.   
 
Model type 1 was the least accurate for both total and recombinant protein prediction 
with highest predictive errors in the supernatant samples at 53.89% and 68.60% 
respectively.  Specific model types 2, 3 and 4 were consistently more accurate for both 
total and recombinant protein prediction.  It may therefore be concluded that varying 
sample type did not enhance model robustness, but actually served to destabilise the 
model.   
 
This study also showed that although both total and recombinant protein could be 
detected and quantified, models developed for total protein prediction exhibited greater 
accuracy than those for recombinant protein.  
 
  Chapter 6  
 156 
 
Due to the limited number of samples available and hence the calibration set size, this 
study outlined the potential of MIR when applied on-line for protein detection.  Also 
as a result of the sample set size, this work presented 2 possible methods of evaluating 
the results, RMSECV and RMSEP.  Both methods produced varying results; however 
the trends observed were identifiable using either method.    
 
Finally, the detergent investigation study provided insight into the necessary 
requirements for further model development, when detergent is present in the process.  
It can be concluded that at typically used detergent concentrations, protein predictions 
would be affected, hence further model development should be used by their presence 
and so conclude that further model development should account for detergent used in 
the process.  
 
6.4  The role of chemometrics and pre-treatments 
This work investigated the potential of MIR spectroscopy as a PAT tool in the 
monitoring of bioprocesses.  However in order realise its full potential and harness its 
capabilities, the importance of chemometrics and spectroscopic pre-treatments must be 
understood.  It is only through the use of chemometric techniques such as PCA and 
PLS can the information obtained via MIR be translated into a usable form.   
 
All 3 studies indicate the importance of careful selection of pre-treatments and number 
of latent variables or principal components.  For PLS models developed in all 3 
studies, the pre-treatments of choice were mean-centering followed by first or second 
derivative application.  These pre-treatments   eliminate the effect of linear baseline 
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off-sets and smooth noisy spectra.  For this instrument and this application, these were 
found to be most effective.   
 
For the PCA completed in study 3, the optimum pre-treatments were mean-centering 
with standard normal variate (SNV).  SNV is a normalisation type of pre-treatment.  
The qualitative information that distinguishes one sample from another is retained but 
information that separates two samples of identical composition, but different 
concentration, is removed.  Therefore this is more applicable for this use. 
 
6.5  Overall conclusions 
The 3 studies presented in this thesis outline the possible applications of MIR when 
used as a PAT tool.  The technique has definite potential in an on-line capacity, where 
continuous real-time monitoring is required.  However limitations do exist, one major 
one of which is the low concentrations of the components it is monitoring.  
Identification of the LOD of a component is imperative to determine if the technique is 
a viable option.  Integration into a control system should only be considered when the 
typical concentrations of components to be monitored are significantly greater than the 
LOD. 
 
Model stability should also be evaluated.  Careful selection of an appropriate training 
set is paramount, along with identification of a validation set that rigorously tests the 
model.  As outlined in study 2, combining synthetic and real culture samples reinforces 
the model, provided the spectra used are of good quality.   
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In terms of a PAT tool, on-line MIR has much to offer.  It is rapid, non-invasive and 
relatively easy to calibrate.  However this technique, when applied to bioprocessing is 
not quite yet “industry ready”.  Industry requires a simple, easy to use, robust 
instrument that is in effect, ready to “plug and play”.  Although MIR has far reaching 
capabilities, they require further development if the technique is to be applied on a 
large scale across the biotechnology sector.  Nevertheless, a little development may go 
a very long way in securing its place as one of the analytical tools of choice going 
forward.          
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Appendix I – MatLab Codes 
 
%% Routine for online monitoring of media components 
 
%% This programme uses command line functions from Eigenvector PLS 
toolbox 
  
% Siobhán Hennessy & Róisín Foley, LiB, School of Biotechnology, DCU 
  
  
%% 
go = 0;  
count = 0; % Global counter which increases by 1 on each iteration 
tic  
%% Import component quatification model 
load comp_model_data 
  
  
while go==0 %Starts a loop to begin programme 
     
start_time = toc; % Loop start time 
count = count + 1; % Update counter 
time(count) = toc / 3600; % Time stamp 
%Insert the directory where spectral files are being imported  
dirlist=dir('C:\Documents and Settings\LiB\My 
Documents\MATLAB\online\*.spc'); 
dirsize = length(dirlist); 
  
if dirsize>0 %Statement to put spectral files in chronological order 
     
    for i = 1 : dirsize  
        filedates(i) = dirlist(i).datenum;  
    end 
%Ensure the most recent spectrum is used     
lastfiledate = max(filedates); 
lastfileindex = findindx(filedates,lastfiledate);%Finds the index of 
the array element closest to chosen value 
  
filename = ['C:\Documents and Settings\LiB\My 
Documents\MATLAB\online\', dirlist(lastfileindex).name];  % This 
should be the same directory as above 
  
s=spcreadr(filename); %Calls plstoolbox function spcreadr to import 
.spc spectral file 
wavenumber=s.axisscale{2}'; %assigned wavenumber data to the variable 
wavenumber 
spectrum=s.data; %assigned spectral data to the variable spectrum 
  
%%sanity check 1 %%  
% Test to see if spectra are of good quality - if absorbance value at 
this 
% point is greater than 0.5 it is likely that the MIR instrument has 
run 
% out of liquid nitrogen 
if spectrum(909)>0.5 
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    %% start again 
    pause(300)  
    continue 
else 
  
 
% Defines regions of the spectrum for each component 
gluc=[950 1450]; glne=[950 1700];amm=[950 1500]; phos=[900 
1320];glte=[900 1760]; lact=[1000 1620];hep=[1000 1250]; bicarb=[960 
1750]; 
wavenumrange = struct('regions', {gluc,glne, amm, phos, glte, lact, 
hep, bicarb}); 
j=length(wavenumrange); 
  
for  k= 1 : j %%SH for i=1:number of components 
       T(k).ex = []; 
        %wnrange(i).regions = [950 1500]; % Override mechanism 
         %% SH sets up an empty matrix for field S.calib  
for r = length(wavenumrange(k).regions)/2 : -1 : 1 
        wavenumrange(k).downlimit(r) = 
max(lamsel(wavenumber,[wavenumber(1)  wavenumrange(k).regions(r*2-
1)],0)); 
        wavenumrange(k).uplimit(r) = 
min(lamsel(wavenumber,[wavenumrange(k).regions(r*2) 
wavenumber(length(wavenumber))],0)); 
         
        T(k).ex = [T(k).ex 
spectrum(:,wavenumrange(k).uplimit(r):wavenumrange(k).downlimit(r))]; 
    end 
T(k).ex; 
end 
  
x_glucose=T(1).ex; 
x_lactate=T(2).ex; 
  
% x_ammonia=T(3).ex;  
% x_phosphate=T(4).ex;  
% x_glutamate=T(5).ex;  
% x_glutamine=T(6).ex;  
% x_HEPES=T(7).ex;  
% x_Bicarb=T(8).ex;  
  
%load gluc_model_data 
  
options.display = 'off'; options.plots = 'none'; %Turns off default 
plot options for pls function 
% Defines variable conc which is the concentration predicted by the 
model 
conc1=pls(x_glucose, mc_2der15_4lvs,options); 
glucose_conc(count)=conc1.pred{1,2};  
conc2=pls(x_lactate, mc_2der15_4lvs,options); 
lactate_conc(count)=conc2.pred{1,2};  
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%Series of additional criteria to be met to ensure no spurious 
predictions 
%are recorded i.e. If concentration is greater than initial media 
%concentration, if concentration is a minus number or if the change 
in 
%concentration is too large to be physically possibly then the 
program 
%waits for the next spectrum and does not send the concentration 
value to 
%csv file where it could be used as part of a control system. 
 
if glucose_conc(count)>10  
elseif glucose_conc(count)<0 
elseif glucose_conc(count)-glucose_conc(count-1)>abs(0.75) 
   continue 
else 
timenow=clock; 
csvwrite('concentration.csv',glucose_conc(count)); %Writes glucose 
concentration to a csv file 
  
if lactate_conc(count)>10  
elseif lactate_conc(count)<0 
elseif lactate_conc(count)-lactate_conc(count-1)>abs(0.75) 
   continue 
else 
timenow=clock; 
csvwrite('concentration.csv',lactate_conc(count)); %Writes lactate 
concentration to a csv file 
  
  
elapsed_time = toc - start_time; 
    remaining_time = 300 - elapsed_time; %This figure can be changed 
according to the frequency of spectral collection.  
    %It is currently set for collection every 5 mins 
    disp(['Waiting for next measurement... in ' 
num2str(remaining_time) ' seconds']) %Displays message on screen 
    disp(' ') 
    %Records the predicted value for each spectrum in a text file in 
    %specified directory. 
    dlmwrite('C:\Documents and Settings\LiB\My 
Documents\MATLAB\MATLAB\spectra_log.txt',[timenow, 
glucose_conc(count),lactate_conc(count)],'-
append','delimiter','\t','newline','pc'); 
    pause(remaining_time) 
    if dirsize==1000 %Programme finished when 1000 spectra have been 
collected. Alternatively press Ctrl+c 
        break; 
end 
end 
end 
end 
end 
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%% Protein Quantification 
 
filename=uigetfile('*.xls'); % gets user to select the excel file 
containing spectral data 
  
  
importfile1(filename); % function to import data from sheet 1 of 
excel file 
  
X=deletecolumn(data,1)'; %deletes the 1st column of the data i.e. the 
column of wavenumbers leaving only the spectral data. 
wavenumber=selectcolumn(data,1); %selected the 1st column of data 
i.e. the wavenumbers. 
  
protein=[1200 1910];  
wavenumrange = struct('regions', {protein}); 
clear protein data data2 colheaders colheaders2 textdata textdata2 
filename; 
  
  
plot(wavenumber, X); %plots the spectra for visual examination 
  
  
  
protein.ex = []; %% SH sets up an empty matrix for field S.calib 
    for r = length(wavenumrange.regions)/2 : -1 : 1 
        wavenumrange.downlimit(r) = 
max(lamsel(wavenumber,[wavenumber(1) wavenumrange.regions(r*2-
1)],0)); 
        wavenumrange.uplimit(r) = 
min(lamsel(wavenumber,[wavenumrange.regions(r*2) 
wavenumber(length(wavenumber))],0)); 
         
protein.ex =  
[protein.ex X(:,wavenumrange.uplimit(r):wavenumrange.downlimit(r))]; 
    end 
x_protein=protein.ex; 
  
figure; 
plot(wavenumrange.uplimit(r):wavenumrange.downlimit(r), x_protein) 
  
clear protein X and r wavenumber wavenumrange; 
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%% Import File Function  
 
function importfile1(fileToRead1) 
%IMPORTFILE(FILETOREAD1) 
%  Imports data from the specified file 
%  FILETOREAD1:  file to read 
 
% Import the file 
sheetName='Sheet1'; 
[numbers, strings] = xlsread(fileToRead1, sheetName); 
if ~isempty(numbers) 
    newData1.data =  numbers; 
end 
if ~isempty(strings) 
    newData1.textdata =  strings; 
    newData1.colheaders =  strings; 
end 
  
% Create new variables in the base workspace from those fields. 
vars = fieldnames(newData1); 
for i = 1:length(vars) 
    assignin('base', vars{i}, newData1.(vars{i})); 
end 
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%% Delete Column Function 
       
function [spec] = deletecolumn(irdata,index) 
irdata(:,index)=[]; 
spec=irdata; 
%deletecol - deletes columns of matrices  
% usage: [X]= deletecol(X1,index)  
%The deleted columns are indicated by the vector index (numbers of 
booleans) 
 
 
%% Select Column Function 
function [spec] = selectcolumn(irdata,index) 
spec=irdata(:,index); 
%selectcol - creates a new data matrix with the selected columns 
% the resulting file corresponds to the selected columns 
% index is a vector of indices (integer) or of booleans 
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Appendix II – 7-Level & 4-Level design matrices 
 
7-Level Partial Factorial Design (calibration matrix development) 
Difference vector:  {5 3 0 1 4 2} 
Cyclic generator:  -3→ 1→ -1→ 2 → 3 → -2→ -3   
Repeater level: 3 
7-level design Sample no. Glucose Glutamine Ammonia Phosphate Glutamate Lactate HEPES Bicarbonate Buffer
0 1 3 3 3 3 3 3 3 3 11
0 2 3 0 1 2 2 5 4 5 13
-3 3 0 1 2 2 5 4 5 3 13
-2 4 1 2 2 5 4 5 3 4 9
-1 5 2 2 5 4 5 3 4 0 10
-1 6 2 5 4 5 3 4 0 5 7
2 7 5 4 5 3 4 0 5 5 4
1 8 4 5 3 4 0 5 5 6 3
2 9 5 3 4 0 5 5 6 2 5
0 10 3 4 0 5 5 6 2 6 4
1 11 4 0 5 5 6 2 6 3 4
-3 12 0 5 5 6 2 6 3 2 6
2 13 5 5 6 2 6 3 2 4 2
2 14 5 6 2 6 3 2 4 6 1
3 15 6 2 6 3 2 4 6 6 0
-1 16 2 6 3 2 4 6 6 1 5
3 17 6 3 2 4 6 6 1 5 2
0 18 3 2 4 6 6 1 5 1 7
-1 19 2 4 6 6 1 5 1 3 7
1 20 4 6 6 1 5 1 3 5 4
3 21 6 6 1 5 1 3 5 2 6
3 22 6 1 5 1 3 5 2 1 11
-2 23 1 5 1 3 5 2 1 1 16
2 24 5 1 3 5 2 1 1 0 17
-2 25 1 3 5 2 1 1 0 6 16
0 26 3 5 2 1 1 0 6 0 17
2 27 5 2 1 1 0 6 0 3 17
-1 28 2 1 1 0 6 0 3 6 16
-2 29 1 1 0 6 0 3 6 5 13
-2 30 1 0 6 0 3 6 5 0 14
-3 31 0 6 0 3 6 5 0 0 15
3 32 6 0 3 6 5 0 0 4 11
-3 33 0 3 6 5 0 0 4 1 16
0 34 3 6 5 0 0 4 1 4 12
3 35 6 5 0 0 4 1 4 3 12
2 36 5 0 0 4 1 4 3 1 17
-3 37 0 0 4 1 4 3 1 6 16
-3 38 0 4 1 4 3 1 6 4 12
1 39 4 1 4 3 1 6 4 4 8
-2 40 1 4 3 1 6 4 4 2 10
1 41 4 3 1 6 4 4 2 0 11
0 42 3 1 6 4 4 2 0 2 13
-2 43 1 6 4 4 2 0 2 3 13
3 44 6 4 4 2 0 2 3 0 14
1 45 4 4 2 0 2 3 0 1 19
1 46 4 2 0 2 3 0 1 2 21
-1 47 2 0 2 3 0 1 2 2 23
-3 48 0 2 3 0 1 2 2 5 20
-1 49 2 3 0 1 2 2 5 4 16
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Sample no. Glucose Glutamine Ammonium Sulphate Potassium Phosphate Glutamate Lactate HEPES Bicarbonate
1 3.00 0.30 1.89 0.73 0.35 1.72 2.23 0.63
2 3.00 0.00 0.63 0.49 0.23 2.87 2.97 1.04
3 0.00 0.10 1.26 0.49 0.59 2.30 3.71 0.63
4 1.00 0.20 1.26 1.21 0.47 2.87 2.23 0.83
5 2.00 0.20 3.14 0.97 0.59 1.72 2.97 0.00
6 2.00 0.50 2.51 1.21 0.35 2.30 0.00 1.04
7 5.00 0.40 3.14 0.73 0.47 0.00 3.71 1.04
8 4.00 0.50 1.89 0.97 0.00 2.87 3.71 1.25
9 5.00 0.30 2.51 0.00 0.59 2.87 4.46 0.42
10 3.00 0.40 0.00 1.21 0.59 3.45 1.49 1.25
11 4.00 0.00 3.14 1.21 0.70 1.15 4.46 0.63
12 0.00 0.50 3.14 1.46 0.23 3.45 2.23 0.42
13 5.00 0.50 3.77 0.49 0.70 1.72 1.49 0.83
14 5.00 0.60 1.26 1.46 0.35 1.15 2.97 1.25
15 6.00 0.20 3.77 0.73 0.23 2.30 4.46 1.25
16 2.00 0.60 1.89 0.49 0.47 3.45 4.46 0.21
17 6.00 0.30 1.26 0.97 0.70 3.45 0.74 1.04
18 3.00 0.20 2.51 1.46 0.70 0.57 3.71 0.21
19 2.00 0.40 3.77 1.46 0.12 2.87 0.74 0.63
20 4.00 0.60 3.77 0.24 0.59 0.57 2.23 1.04
21 6.00 0.60 0.63 1.21 0.12 1.72 3.71 0.42
22 6.00 0.10 3.14 0.24 0.35 2.87 1.49 0.21
23 1.00 0.50 0.63 0.73 0.59 1.15 0.74 0.21
24 5.00 0.10 1.89 1.21 0.23 0.57 0.74 0.00
25 1.00 0.30 3.14 0.49 0.12 0.57 0.00 1.25
26 3.00 0.50 1.26 0.24 0.12 0.00 4.46 0.00
27 5.00 0.20 0.63 0.24 0.00 3.45 0.00 0.63
28 2.00 0.10 0.63 0.00 0.70 0.00 2.23 1.25
29 1.00 0.10 0.00 1.46 0.00 1.72 4.46 1.04
30 1.00 0.00 3.77 0.00 0.35 3.45 3.71 0.00
31 0.00 0.60 0.00 0.73 0.70 2.87 0.00 0.00
32 6.00 0.00 1.89 1.46 0.59 0.00 0.00 0.83
33 0.00 0.30 3.77 1.21 0.00 0.00 2.97 0.21
34 3.00 0.60 3.14 0.00 0.00 2.30 0.74 0.83
35 6.00 0.50 0.00 0.00 0.47 0.57 2.97 0.63
36 5.00 0.00 0.00 0.97 0.12 2.30 2.23 0.21
37 0.00 0.00 2.51 0.24 0.47 1.72 0.74 1.25
38 0.00 0.40 0.63 0.97 0.35 0.57 4.46 0.83
39 4.00 0.10 2.51 0.73 0.12 3.45 2.97 0.83
40 1.00 0.40 1.89 0.24 0.70 2.30 2.97 0.42
41 4.00 0.30 0.63 1.46 0.47 2.30 1.49 0.00
42 3.00 0.10 3.77 0.97 0.47 1.15 0.00 0.42
43 1.00 0.60 2.51 0.97 0.23 0.00 1.49 0.63
44 6.00 0.40 2.51 0.49 0.00 1.15 2.23 0.00
45 4.00 0.40 1.26 0.00 0.23 1.72 0.00 0.21
46 4.00 0.20 0.00 0.49 0.35 0.00 0.74 0.42
47 2.00 0.00 1.26 0.73 0.00 0.57 1.49 0.42
48 0.00 0.20 1.89 0.00 0.12 1.15 1.49 1.04
49 2.00 0.30 0.00 0.24 0.23 1.15 3.71 0.83
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Sample no. Glucose Glutamine Ammonia Phosphate Glutamate Lactate HEPES Bicarbonate
1 3.00 0.30 0.52 0.51 0.35 0.50 2.23 0.62
2 3.00 0.00 0.17 0.34 0.23 0.83 2.97 1.04
3 0.00 0.10 0.34 0.34 0.59 0.66 3.71 0.62
4 1.00 0.20 0.34 0.85 0.47 0.83 2.23 0.83
5 2.00 0.20 0.86 0.68 0.59 0.50 2.97 0.00
6 2.00 0.50 0.69 0.85 0.35 0.66 0.00 1.04
7 5.00 0.40 0.86 0.51 0.47 0.00 3.71 1.04
8 4.00 0.50 0.52 0.68 0.00 0.83 3.71 1.25
9 5.00 0.30 0.69 0.00 0.59 0.83 4.46 0.42
10 3.00 0.40 0.00 0.85 0.59 1.00 1.49 1.25
11 4.00 0.00 0.86 0.85 0.70 0.33 4.46 0.62
12 0.00 0.50 0.86 1.02 0.23 1.00 2.23 0.42
13 5.00 0.50 1.03 0.34 0.70 0.50 1.49 0.83
14 5.00 0.60 0.34 1.02 0.35 0.33 2.97 1.25
15 6.00 0.20 1.03 0.51 0.23 0.66 4.46 1.25
16 2.00 0.60 0.52 0.34 0.47 1.00 4.46 0.21
17 6.00 0.30 0.34 0.68 0.70 1.00 0.74 1.04
18 3.00 0.20 0.69 1.02 0.70 0.17 3.71 0.21
19 2.00 0.40 1.03 1.02 0.12 0.83 0.74 0.62
20 4.00 0.60 1.03 0.17 0.59 0.17 2.23 1.04
21 6.00 0.60 0.17 0.85 0.12 0.50 3.71 0.42
22 6.00 0.10 0.86 0.17 0.35 0.83 1.49 0.21
23 1.00 0.50 0.17 0.51 0.59 0.33 0.74 0.21
24 5.00 0.10 0.52 0.85 0.23 0.17 0.74 0.00
25 1.00 0.30 0.86 0.34 0.12 0.17 0.00 1.25
26 3.00 0.50 0.34 0.17 0.12 0.00 4.46 0.00
27 5.00 0.20 0.17 0.17 0.00 1.00 0.00 0.62
28 2.00 0.10 0.17 0.00 0.70 0.00 2.23 1.25
29 1.00 0.10 0.00 1.02 0.00 0.50 4.46 1.04
30 1.00 0.00 1.03 0.00 0.35 1.00 3.71 0.00
31 0.00 0.60 0.00 0.51 0.70 0.83 0.00 0.00
32 6.00 0.00 0.52 1.02 0.59 0.00 0.00 0.83
33 0.00 0.30 1.03 0.85 0.00 0.00 2.97 0.21
34 3.00 0.60 0.86 0.00 0.00 0.66 0.74 0.83
35 6.00 0.50 0.00 0.00 0.47 0.17 2.97 0.62
36 5.00 0.00 0.00 0.68 0.12 0.66 2.23 0.21
37 0.00 0.00 0.69 0.17 0.47 0.50 0.74 1.25
38 0.00 0.40 0.17 0.68 0.35 0.17 4.46 0.83
39 4.00 0.10 0.69 0.51 0.12 1.00 2.97 0.83
40 1.00 0.40 0.52 0.17 0.70 0.66 2.97 0.42
41 4.00 0.30 0.17 1.02 0.47 0.66 1.49 0.00
42 3.00 0.10 1.03 0.68 0.47 0.33 0.00 0.42
43 1.00 0.60 0.69 0.68 0.23 0.00 1.49 0.62
44 6.00 0.40 0.69 0.34 0.00 0.33 2.23 0.00
45 4.00 0.40 0.34 0.00 0.23 0.50 0.00 0.21
46 4.00 0.20 0.00 0.34 0.35 0.00 0.74 0.42
47 2.00 0.00 0.34 0.51 0.00 0.17 1.49 0.42
48 0.00 0.20 0.52 0.00 0.12 0.33 1.49 1.04
49 2.00 0.30 0.00 0.17 0.23 0.33 3.71 0.83
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4-Level Partial Factorial Design (validation matrix development) 
Difference vector:  {0 2 1} 
Cyclic generator:  -1→ 1→ 2 → 1  
Repeater level: 2 
 
Units added to each sample 
 
4-level design Sample No. Glucose Glutamine Ammonia Phosphate Glutamate Lactate HEPES Bicarbonate Buffer
-2 1 0 0 0 0 0 0 0 0 25
-2 2 0 1 1 4 1 0 3 3 12
-1 3 1 1 4 1 0 3 3 1 11
-1 4 1 4 1 0 3 3 1 3 9
2 5 4 1 0 3 3 1 3 0 10
-1 6 1 0 3 3 1 3 0 4 10
-2 7 0 3 3 1 3 0 4 4 7
1 8 3 3 1 3 0 4 4 3 4
1 9 3 1 3 0 4 4 3 4 3
-1 10 1 3 0 4 4 3 4 0 6
1 11 3 0 4 4 3 4 0 1 6
-2 12 0 4 4 3 4 0 1 1 8
2 13 4 4 3 4 0 1 1 4 4
2 14 4 3 4 0 1 1 4 1 7
1 15 3 4 0 1 1 4 1 0 11
2 16 4 0 1 1 4 1 0 3 11
 
 
 
 
Concentration of each compound added to each sample  
 
Sample No. Glucose Glutamine Ammonium Sulphate Potassium Phosphate Glutamate Calcuim Lactate HEPES Bicarbonate
1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2 0.00 0.15 0.92 1.46 0.16 0.00 3.39 0.94
3 1.52 0.15 3.68 0.36 0.00 2.62 3.39 0.31
4 1.52 0.60 0.92 0.00 0.49 2.62 1.13 0.94
5 6.08 0.15 0.00 1.09 0.49 0.87 3.39 0.00
6 1.52 0.00 2.76 1.09 0.16 2.62 0.00 1.25
7 0.00 0.45 2.76 0.36 0.49 0.00 4.52 1.25
8 4.56 0.45 0.92 1.09 0.00 3.49 4.52 0.94
9 4.56 0.15 2.76 0.00 0.66 3.49 3.39 1.25
10 1.52 0.45 0.00 1.46 0.66 2.62 4.52 0.00
11 4.56 0.00 3.68 1.46 0.49 3.49 0.00 0.31
12 0.00 0.60 3.68 1.09 0.66 0.00 1.13 0.31
13 6.08 0.60 2.76 1.46 0.00 0.87 1.13 1.25
14 6.08 0.45 3.68 0.00 0.16 0.87 4.52 0.31
15 4.56 0.60 0.00 0.36 0.16 3.49 1.13 0.00
16 6.08 0.00 0.92 0.36 0.66 0.87 0.00 0.94
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Concentration of each component added to each sample 
Sample No. Glucose Glutamine Ammonia Phosphate Glutamate Lactate HEPES Bicarbonate
1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
2 0.00 0.15 0.25 1.00 0.16 0.00 3.39 0.94
3 1.52 0.15 1.00 0.25 0.00 0.75 3.39 0.31
4 1.52 0.60 0.25 0.00 0.49 0.75 1.13 0.94
5 6.08 0.15 0.00 0.75 0.49 0.25 3.39 0.00
6 1.52 0.00 0.75 0.75 0.16 0.75 0.00 1.25
7 0.00 0.45 0.75 0.25 0.49 0.00 4.52 1.25
8 4.56 0.45 0.25 0.75 0.00 1.00 4.52 0.94
9 4.56 0.15 0.75 0.00 0.66 1.00 3.39 1.25
10 1.52 0.45 0.00 1.00 0.66 0.75 4.52 0.00
11 4.56 0.00 1.00 1.00 0.49 1.00 0.00 0.31
12 0.00 0.60 1.00 0.75 0.66 0.00 1.13 0.31
13 6.08 0.60 0.75 1.00 0.00 0.25 1.13 1.25
14 6.08 0.45 1.00 0.00 0.16 0.25 4.52 0.31
15 4.56 0.60 0.00 0.25 0.16 1.00 1.13 0.00
16 6.08 0.00 0.25 0.25 0.66 0.25 0.00 0.94
 
 
   
 
